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Milk, whether maternal or formulated, provides the sole source of nutrition to infants in 
the early stages of life, providing critical micronutrients, support for the immune function 
and primary dietary macronutrients including lipids. In healthy adults, lipids are primarily 
digested in the small intestine. However, for infants, the neonatal small intestine is not 
fully developed after birth, so the gastric environment plays a more significant role in 
milk fat digestion. Clinical studies have shown that maternal milk fat is digested more 
efficiently than lipids in infant formulae in infants under infant gastric conditions. 
Compositional differences, the structure of the oil droplets, and especially the interfacial 
composition may all play a crucial role in influencing lipid digestibility in the infant's 
stomach. In this thesis, the simulated gastric digestion of model emulsions and 
commercial infant formula was studied. The model emulsions comprised either a 
phospholipid or complexed protein-phospholipid interface while keeping all other facets 
of emulsion properties equivalent. Gastric digestion of these emulsions was carried out 
across variable pH conditions using an analogue gastric lipase, alone and in combination 
with pepsin with findings providing insights into the role of each enzyme and their 
combined effect on gastric lipolysis. 
The rate and extent of lipolysis were characterised, along with morphological changes 
to the structure of the oil droplets. Results showed that gastric lipolysis might be 
influenced by pH conditions in the gastric environment when lipase was present alone 
in the simulated gastric fluid. The inclusion of pepsin resulted in significant structural 
changes when emulsions were stabilised with protein, in terms of droplet aggregation, 
size and morphology. However, no significant differences in the extent of lipolysis were 
determined. Thus, while the protein interface of both model and formulated emulsions 
was not observed to be a barrier for gastric lipolysis. Proteolysis of protein stabilised 
emulsions may lead to very different structural outcomes during gastric digestion when 
compared to phospholipid stabilised emulsions. While the research within this thesis 
demonstrates how the gastric environment influences emulsion structure as a 
consequence of interfacial composition, any specific relationship between structure and 
relative rate of gastric lipolysis currently remains undetermined. This research also 
highlights some of the ongoing challenges in the use of in vitro models to provide 
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Chapter 1 Introduction and key objectives 
Human breast milk is the only ideal food for infants during the early months of life, to 
achieve optimal growth rates, development and health. WHO (World Health 
Organization) recommends exclusive breastfeeding for the first six months (WHO, 
2001), and breastfeeding can continue until two years of age or longer. Human milk 
provides nutritional and breastfeeding also provides non-nutritional benefits for infants. 
It is not only the best food for neonates to achieve optimal growth and development, but 
also is crucial for neonatal health and later stages for life. However, while human breast 
milk plays this essential role in neonatal diet and nutrition, some mothers are not able to 
breastfeed because of disease, discomfort or busy working life. Thus, infant formulae 
have been developed to provide alternative options for infant feeding. 
Lipids, primarily triglycerides, in human milk represent approximately half of the 
energy intake for neonates (Innis, 2004; Manson & Weaver, 1997). Besides the energy 
provided, complex lipids such as gangliosides and phospholipids in the milk globule 
membrane, also play essential roles in infant brain development, immunity, growth and 
development. 
Human breast milk and infant formulae are emulsion systems where lipid droplets are 
dispersed in a continuous aqueous phase comprising proteins, lactose, minerals and 
vitamins as soluble components. When ingested, the milk fat will keep its initial oil in 
water emulsion structure through to the stomach where lipid digestion is initiated. As 
lipid digestion is an interfacial process, the structure of the milk lipid emulsion 
processes. 
Thus, the structure of milk lipid plays a vital role in the process of lipid digestion. The 
structure of milk fat globules and the dynamics of the oil/water interface are influenced 
by the biochemical and biophysical environment in the gastrointestinal (GI) tract, which 
will in turn potentially have related consequences for the rate and efficiency of lipid 
digestion. 
Clinical studies have shown the extent of lipid digestion of human breast milk is greater 
than that of infant formulae (usually based on vegetable oil and bovine milk proteins in 
neonates (Armand, Hamosh, Mehta, & Angelus, 1994; Armand, Hamosh, et al., 1996; 
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Hamosh, 1996). This is a somewhat paradoxical finding given that the droplet size of 
formula milk is typically one order of magnitude smaller than that of maternal milk and 
should provide greater surface area available for the binding of digestive lipase 
enzymes. Thus, the main differences between human breast milk and infant formula do 
not only lie in composition, nutritional or immunity value, but that their structural 
differences are influential to the efficacy of the neonatal digestion process. Notably, 
while formula emulsions typically comprise protein-coated oil droplets, human breast 
milk is secreted from the apocrine cell of the mammary gland. Thus the milk fat globule 
has a unique tri-layer milk fat globule membrane (Keenan & Patton, 1995) 
predominantly made up of phospholipids, which provides a significantly different 
interfacial structure to that of formula milk. 
Some studies have suggested that emulsion structure plays a fundamental part in fat 
digestion in the GI tract (Armand, Borel, et al., 1994a; Armand, Borel, et al., 1996a; 
Armand et al., 1999; Berton et al., 2012; Fave, Coste, & Armand, 2004; Golding, 2014; 
Golding & Wooster, 2010; Golding et al., 2011). Recently, researchers have started to 
realise that the milk fat globule membrane may also play a critical part in facilitating fat 
digestion (Gallier et al., 2013; Gallier, Ye, & Singh, 2012). However, a knowledge gap 
still exists in fully determining the relationship between emulsion structure and fat 
digestion in neonates. 
Moreover, as the development of small intestine in infants is immature, milk fat could 
not be able to digest efficiently in by lipases in the small intestine as adults. Therefore 
lipase in the gastric phase may play a crucial part in the digestion of lipids for infants. 
When milk emulsions are exposed to the biochemical and physical environment in the 
neonatal GI tract, the properties of the oil/water interface may change. This may have a 
decisive impact on enzyme adsorption, rate of lipid digestion and absorption, and even 
later growth and development for infants. 
Therefore, this PhD project aims to investigate how emulsion structure dynamics in 
model emulsions representative of infant milk and infant formula influence the extent of 
lipolysis during simulated gastric digestion and exploring co-dependency of the gastric 
enzymes (protease and lipase). 
Thus, the key research questions and the corresponding research objectives are: 
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• Do structural dynamics of emulsions during digestion influence the rate and extent 
of lipolysis during gastric digestion? 
• To what extent is the rate of lipolysis influenced by the changing pH environment 
within the stomach? 
• To what extent do the concerted actions of lipase and pepsin influence the rate of 
lipolysis on protein-stabilised emulsions?  
We also present the following main hypotheses in support of the above research 
questions: 
• The structural changes of emulsion droplets during gastric digestion are influenced 
by the generation of free fatty acids during lipolysis. 
• Phospholipid interfaces provide a biologically more favourable environment for the 
adsorption of lipase. 
• Lipolysis of protein stabilised emulsions is facilitated by the concerted action of 
both pepsin and gastric lipase.  
• The dynamic pH environment within the stomach (as influenced by the buffering 
effect of consumed milk) can influence the relative activity of pepsin and lipase. 
• The free fatty acids generated from gastric lipolysis can alter the interfacial 
composition during lipolysis, and thus may inhibit subsequent lipase adsorption. 
Therefore, accordingly, the research objectives are: 
• Develop a model that uses electrostatic attraction in protein-phospholipid multi-
layered emulsions as substrates for in vitro experiments. 
• Determine the relationship between emulsion structure and the extent of lipolysis 
for these model emulsions and investigate how gastric conditions influence this 
relationship. 
• Compare the behaviour of model oil in water emulsions to those of infant formulae 
and study how different emulsion structures influence the extent of lipolysis. 
• Compare the behaviour of the multi-layered emulsion with that of infant formulae. 
The next chapter will introduce the literature that identifies the current gaps and 




Chapter 2 Literature review 
2.1 Introduction 
This literature review aims at understanding milk lipid digestion in the neonatal GI tract. 
The gastrointestinal conditions are essential for efficient lipid digestion in infants, and it 
is known that the processes by which infants digest fat differ from those in adults. The 
review will focus on understanding variables in the gastrointestinal tract that influences 
lipid digestion, previous studies from in vitro and in vivo approaches and recent progress 
in emulsion structural changes and its relations to lipid digestion. This information will 
assist in answering the research questions of this project. 
2.2 Neonatal gastrointestinal (GI) tract 
The neonatal diet shifts from predominantly carbohydrates during fetal development to 
include higher amounts of fat after birth. At this stage, milk is the only source of food for 
newborns to provide energy and nutrients for growth and development. Among the 
necessary macronutrients, lipids provide energy and facilitate brain development 
(Hamosh, Iverson, Kirk, & Hamosh, 1994; Martin, Ling, & Blackburn, 2016; Uauy & 
Castillo, 2003). Maternal milk, in particular, contains all necessary macro- and micro-
nutrients, bioactive components and immunological factors that are critical for the 
survival and growth of infants.  
In adults, gastric lipolysis of the triglycerides in foods accounts for about 10-30% of the 
total lipolysis (Armand, Borel, et al., 1994b; Armand, Borel, et al., 1996b; Armand et al., 
1999; Fave et al., 2004) while duodenal lipolysis accounts for 42-45%  (Armand, Borel, 
et al., 1996a). However, in infants, lipid hydrolysis in the gastric phase can reach up to 
40% (Armand, Hamosh, et al., 1994; Armand, Hamosh, et al., 1996; Hamosh, 1979a; 
Roman et al., 2007). Due to the immaturity of the neonatal GI tract, secretion of 
pancreatic digestive enzymes (lipase, trypsin and amylase) and bile salts are generally 
much lower than that of adults (Figure 2.1). Therefore, alternative pathways take on 
increased relevance for milk digestion in infants, which may result in greater reliance on 





Figure 2.1 Diagrammatic representation the main changes in the digestive function in fetus, 
newborn and child, graph adapted from Thureen (Fordtran & Sleisenger, 1989; Thureen, 
2006). Reproduce with permission from Cambridge University Press. 
The milk emulsions ingested by infants are first mixed with a small amount of saliva. 
Whether digestion of milk lipids is initiated by lingual lipase is still controversial, so far 
there was no evidence showing the existence human lingual lipase  (Hamosh, 1979b; 
Nguyen, Bhandari, Cichero, & Prakash, 2015). However, the mixture passes through the 
oral cavity quickly and then enters the stomach. The stomach plays an indispensable role 
for neonatal lipid digestion, where it provides digestive enzymes, an acidic environment 
that with gastric mixing contribute to the process of lipid digestion. Therefore, the 
following part will focus on the gastric digestive phase in the neonates as well the small 
intestinal phase which might be of further interest in this project–while the in vitro 
research component has a specific focus on the gastric digestion. 
2.2.1 Gastric phase 
2.2.1.1 Human gastric lipase 
Human gastric lipase (HGL, EC 3.1.1.3) is a hydrophobic enzyme secreted from the chief 
cells from glands in the gastric fundus (K. E. Barrett, Barman, & Boitano, 2010; Carriere, 
Barrowman, Verger, & Laugier, 1993; Hamosh, 1990; Roussel et al., 1999). Human 
gastric lipase contributes to about 10-30% of lipolysis in the GI tract of healthy adults, 
converts triglycerides to diglycerides and liberates long-chain fatty acids (Carriere et al., 
1993). Although lipid digestion by gastric lipase may be less effective than lipolysis in 
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the small intestine for adults—where the majority of lipid digestion takes place—it may 
be more critical in neonatal lipid digestion and in patients with pancreatitis where the 
secretion of lipase is compromised (Muller, McCollum, Trompeter, & Harries, 1975). 
HGL is stable in the acidic gastric environment and does not depend on the action of bile 
salts and other specific protein cofactors for its action (Hamosh et al., 1981; Roussel et 
al., 1999), and it is not vulnerable to pepsin proteolysis (Bernback & Blackberg, 1989). 
Purified HGL from human gastric aspirates had a molecular weight of approximately 
50,000 Da (Bodmer et al., 1987). The molecular weight was predicted to be 43,162 Da 
by molecular cloning of a cDNA coding for human gastric lipase (Bodmer et al., 1987). 
Like many other lipases, HGL has a /-hydrolase fold core domain and a Ser-His-Asp 
catalytic triad in the active site and an oxyanion hole (Roussel et al., 1999). Notably, the 
N-terminal tetrapeptide (Leu-Phe-Gly-Lys-) is critical for HGL binding to lipid emulsion 
substrates. When trypsin cleaves the N-terminal tetrapeptide end, HGL is not able to bind 
at the oil/water interface and hydrolyse the emulsified lipid substrate (Bernback & 
Blackberg, 1989). The crystal structure of recombinant HGL (rHGL) showed three 
structurally independent elements the “lid”, “cap” and “core” domains (Figure 2.2). The 
active site (shown as red) lies beneath the lid and cap domain. The lid and cap domains 
may play an essential role in the interaction between HGL and lipid substrates. When the 
lid is removed from rHGL, the active site is accessible to the oil/water interface on the 
lipid substrate, and the hydrophobic residues of the cap domain form a ring around the 
active site (Figure 2.3). This hydrophobic surface may align with the oil/water interface 
of the lipid substrate, ensuring the rHGL bind and interact with the substrate (Miled et al., 
2003; Roussel et al., 1999). Hence the lid domain combined with the cap domain may 






Figure 2.2 Corey-Pauling-Koltun view of the 
recombinant HGL (rHGL) with core domain 
(yellow), cap domain (blue) and lid domain 
(green). Graph adapted from Miled et al. 
(Miled et al., 2003). Reproduce with 
permission from Elsevier. 
 
Figure 2.3 Corey-Pauling-Koltun view of the 
rHGL with catalytic triad (red), core domain 
(yellow), cap domain (blue), and the 
putative lid (given by a C trace in green). 
Graph adapted from Roussel et al. (Roussel 
et al., 1999). Reproduce with permission 
from American Soc for Biochemistry & 
Molecular Biology.
Poulsen et al. (2005) used cutinase to show that the environment around the active site 
might be more important than the ambient pH in the bulk solution. They proposed that 
binding of lipase to the oil/water interface could form a compartment around the active 
site separate from the bulk solution, so blocking the chemical communication between 
the site and solution. Thus, the enzymatic reaction may operate in a different environment 
than in the bulk solution so that the local pKa of the active site could be more important 
than the optimal ambient pH in describing the kinetics of lipolysis. 
Since a considerable amount of proteolysis by pepsin also takes place in the stomach, it 
is useful to note that the pH in the physiological environment of the stomach generally 
allows both lipase and pepsin to act together, with the possible exception of the pH 
occurring in the fasted state, or at post-prandially elevated levels. In these cases, the pH 
(very acidic) may be outside the optimum pH range of the lipase. HGL is stable at a pH 
2.0 to 7.0 (Ville, Carriere, Renou, & Laugier, 2002), while its optimal range is from 3.0 
8 
 
to 6.0 (Carriere et al., 1991; Gargouri, Sarda, et al., 1986; Roussel et al., 1999; Ville et 
al., 2002). It may lose its activity at a very low pH level, such as in the fasting state 
(Carriere et al., 1993; Hamosh et al., 1981; Roussel et al., 1999; Ville et al., 2002). The 
local chemical environment near the active site of gastric lipase may affect the lipolytic 
products during gastric lipolysis. When gastric pH is within the optimal range for HGL, 
the enzyme may carry positive charges as its isoelectric point lies between pH 6.8 and 7.3 
(Moreau et al., 1992). Depending on the pKa values of the fatty acids, if they are in the 
optimal pH range of HGL, fatty acids liberated from lipolysis may carry negative charges. 
If the positive charges are on the active site of HGL, free negative fatty acids liberated 
from lipolysis may be trapped in the active site by electrostatic attraction affecting the 
local environment around the enzyme. In this case, the speed of reaction may slow down 
as the active site would not be able to access the substrate. However, since little evidence 
exists on where the positive charges are located on HGL, its isoelectric point may not be 
critical in understanding its impact on lipolysis. Even though a maximum reaction rate 
can be obtained over the optimum pH range, the final digestion rate is dependent on 
several other factors. 
HGL has a stereoselective preference for the sn-3 position of triglycerides (Rogalska, 
Ransac, & Verger, 1990), thereby releasing a single fatty acid through hydrolysis (as 
opposed to pancreatic lipase that generates two fatty acids and a monoglyceride). The 
main difference between lipases and other enzymes which act on soluble substrates is that 
they work at the oil/water interface. The presence of emulsion droplets in the stomach 
can facilitate the catalysis process for lipase adsorption, thanks to the large surface area 
provided by the droplets. This process is much less effective when liquid oil is layered in 
the stomach, though gastric lipase has been found to act on soluble short-chain fat like 
vinyl butyrate in solution form (Chahinian et al., 2006). HGL has also been found to 
release both long- and short-chain fatty acids from the triglycerides (Gargouri, Pieroni, et 
al., 1986; Rogalska et al., 1990). The rate of lipolysis by HGL has been measured as 1160 
U/mg for tributyrin and 620 U/mg for Intralipid (Gargouri, Sarda, et al., 1986) at their 
optimal conditions—tributyrin (short-chain fatty acid) at pH 6.0 and Intralipid (mainly 
long-chain fatty acid) at pH 5.0. The kinetic properties of lipase differ from those enzymes 
which act on soluble substrates since the activity of HGL is related to the relative 
emulsion surface area—with smaller droplets providing an increasing number of 
available binding sites than larger droplets. Accordingly, the rate of lipolysis for fine 
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emulsions has been found to be faster than that for coarse emulsions (Armand et al., 1999; 
Borel et al., 1994). Thus the kinetic properties of lipolysis can be influenced by the 
adsorption of lipase at the oil/water interface as well as the interactions between the active 
site of lipase and its substrates. 
2.2.1.2 Pepsin 
Digestion of protein starts within the stomach. The acidic environment in the stomach 
partially denatures some dietary proteins, unfolding the structure and providing easier 
access for pepsin to hydrolyse the peptide bonds (Stipanuk & Caudill, 2013; Wildman & 
Medeiros, 1999). Similar to the small intestinal trypsin, pepsin is also an endopeptidase, 
it cleaves the internal rather than the terminal peptide bonds of proteins. Pepsin is the only 
protease in the stomach, which hydrolyses peptide bonds, breaking proteins down into 
oligopeptides and amino acids before further hydrolysis by the small intestinal proteases. 
Pepsin has broad specificity, preferably cleaving proteins at tyrosine, leucine and 
phenylalanine residues (Oka & Morihara, 1970; Trout & Fruton, 1969; Untersmayr & 
Jensen-Jarolim, 2008). The zymogen form of pepsin ̶ pepsinogen is secreted from the 
gastric chief cells.  The acidic environment within the stomach activates the pepsinogen. 
It happens spontaneously by cleavage of a peptide at the N-terminal of pepsinogen (A. J. 
Barrett, Woessner, & Rawlings, 2012). The activated pepsin also further converts 
pepsinogen into pepsin by autocatalysis. Gastric proteolysis does not make a significant 
contribution to protein digestion in the stomach especially for newborns (Mason, 1962). 
An in vivo study showed only 15% of gastric proteolysis of total ingested protein from 
human milk or infant formula in preterm infants (Henderson, Hamosh, Armand, Mehta, 
& Hamosh, 1998). 
Pepsins are stable under an acidic environment with maximum activity being achieved at 
pH 2. At pH > 5, pepsins gradually lose their activity (Johnston, Dettmar, Bishwokarma, 
Lively, & Koufman, 2007). The pKa values of the active sites are 1.57 (pKa1) and 5.02 
(pKa2) (Lin et al., 1992; Rawlings & Salvesen, 2013). These kinetic parameters can be 
used to calculate the maximum velocity of proteolysis at certain pH levels. During the 
digestion of protein stabilised emulsions, pepsin may work in concert with gastric lipase 
for lipolysis, by removing the protein from the oil/water interface thus facilitating lipase 
adsorption and lipolysis (Lueamsaisuk, Lentle, MacGibbon, Matia-Merino, & Golding, 
2015). Accordingly, pepsin may also play an important role in infants when they are fed 
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with infant formula since the oil droplets are mainly coated with milk proteins. This 
consideration does not necessarily apply when dealing with the digestion of maternal milk, 
which is predominantly stabilised by phospholipids. The pepsin output in full-term 
infants has been found to range from 0.19 to 0.32 mg/mL/hr/kg, being lower than that in 
adults ranging from 0.47 to 0.73 mg/mL/hr/kg (Agunod, Yamaguchi, Lopez, Luhby, & 
Glass, 1969). The fasting activity of pepsin measured on haemoglobin substrate was 
found to be 63 U/mL/kg in premature infants. The value in adults has been found to be 
much higher ranging from 942 to 1333 U/mL (Armand et al., 1995). Gastric enzymatic 
secretions, enzyme activity, and other variables during both fasting and postprandial 
states regarding lipid digestion (Table 2.1) show differences between full-term infants 
and adults. 
Table 2.1 A selection of parameters in the gastric phase compared full-term infants to adults. 
Reproduce with permission from Taylor & Francis. 
Parameters Full-term infants Adults 
Total volume (mL) F:2 - 2.65 (1 day) F: 24-45 
Secretions (mL/h/kg) F:1 (1 week) 
F: 79.7  37.9 mL/h 
S: 210  51.3 mL/h 
Ionic strength (mM) 72 - 152 F: 100 - 150 
pH 
Depending on the buffering 
capacity of milk and 
frequency of feeding 
2.0 - 7.5 
pH = - 0.015 T + 6.53 
Depending on the buffering 
capacity of the meal 
1.0 - 2.5 




F:38.9  22.8 
PP: N.A. 
F: 5.7 - 9.9 
S: 5.2 - 7.5 
Pepsin activity 
(U or mg/mL) 
S: 0.16 - 0.18 mg/mL 
(10-110 days) 
F: 942 - 1333 U/mL 





(Rate of emptying to the 
duodenum, Kcal/min) 
Infant formulae 
76 - 87 
Human milk 
48 - 61 
0.63 - 0.43 
Liquid meal: zero-order kinetics 
T ½ = 10 - 60 
Solid meal: first-order kinetics 
T ½ = 60 - 277 
2 
Emptying dependent on the 
volume, osmotic pressure and 
caloric content of the meal 
F, Fasting; T, Time after feeding (min); PP, Postprandial; S, Stimulated; N.A., not available; T1/2, gastric 
emptying half time. Content in the table was adapted from Bourlieu et al. (2014).  
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2.2.1.3 The secretion of hydrochloric acid 
Studies have shown that immediately after birth, the gastric pH of neonates may be 
alkaline due to ingestion of uterus amniotic fluid. Gastric pH can be influenced by the 
frequency and volume of feeding and the buffering effect of milk. In healthy adults, the 
fasting gastric pH is from 1 to 2, and postprandial gastric pH is usually from 4 to 6. 
However in the neonates, the gastric pH level is relatively higher than that in adults 
(Dressman et al., 1990; Russell et al., 1993) and the secretion of hydrochloric acid (HCl) 
is also much lower, rising to adult level after one year of age (Bourlieu et al., 2014). 
 
Figure 2.4 The fasting and postprandial gastric pH in preterm infants (Armand, Hamosh, et al., 
1996; Cavell, 1983; Mason, 1962; Mitchell, McClure, & Tubman, 2001; Omari & Davidson, 
2003; Roman et al., 2007). The figure was adapted from Bourlieu et al. (Bourlieu et al., 2014). 
Reproduce with permission from Taylor & Francis. 
The changing gastric pH after feeding in preterm infants shows a similar trend as with 
full-term infants (Figures 2.4 and 2.5). For healthy newborns, the pH level can range from 
2.0 to 7.1. During the fasting state, the mean gastric pH value usually stays around 3.5. 
However, after feeding, milk diluted with HCl acts as a buffer, so the pH increases and 
stays at a range between 7.1 and 5.2 for up to 120 min. A pH peak value (6.0-7.0) can be 
detected for about 60 mins after which the pH gradually starts to fall, with the postprandial 
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gastric pH dropping back below 3.0 after four hours of digestion. Another study has 
shown similar gastric pH values in infants ranging from 2.5 to 5.5 (Agunod et al., 1969). 
 
Figure 2.5 The fasting and postprandial pH of the stomach content from 25 healthy full-term 
infants (mean value) (Chatterton, Rasmussen, Heegaard, Sørensen, & Petersen, 2004; Mason, 
1962). Reproduce with permission from Elsevier. 
Consequently, due to the relatively high level of pH in the fasting and postprandial phase, 
the pH in the neonatal stomach seems to always fall outside the optimal pH (2.0) for 
pepsin activity, as opposed to the pH range (2.0-6.0) observed in the adult stomach which 
is more appropriate for human gastric lipase activity. Thus, only minor proteolysis could 
be expected to take place in the neonatal stomach, whereas triglycerides are partially 
digested in the stomach. Thus, gastric lipolysis may play a more critical role in initiating 
lipid digestion and facilitate lipolysis in the later stage in the small intestine. 
2.2.2 Intestinal phase 
1.1.1.1 Pancreatic lipase and bile salts 
After the chyme passes through the stomach and enters into the small intestine, gastric 
lipase may still retain some activity at the duodenal phase (Carriere et al., 1993; Miled et 
al., 2000), thus lipid digestion may take place under the action of both, gastric lipase and 
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pancreatic lipase, in the presence of bile salts. In the intestinal phase, pancreatic lipase is 
the primary lipase, preferentially hydrolysing triglycerides and diglycerides in the digesta 
at the sn-1 and sn-3 positions, producing 2-monoglycerides and free fatty acids. Since the 
digestive tract has been fully developed in children and adults, pancreatic enzymatic 
secretions and biliary secretions are sufficient for full lipid digestion and absorption. 
Human pancreatic lipase (HPL) is active at neutral pH, more precisely in the range of 4.5 
to 7.5 with an optimal activity at around 6.5 (Carriere et al., 1993). During intestinal 
lipolysis, HPL may be inhibited by small-molecule surfactants such as Tween 80 
(Gargouri, Julien, Bois, Verger, & Sarda, 1983). 
 
Figure 2.6 i) Pancreatic lipase could not bind to the emulsion interface by its own. The 
activation of this enzyme needs co-lipase, bile salts and calcium. ii) Binding of co-lipase binds 
to pancreatic lipase. This complex facilitates the exposure of the active sites of pancreatic 
lipase and its adsorption on the oil/water interface. iii) Adsorption of the complex of co-lipase 
and pancreatic lipase can be inhibited by some surfactants. iv)Those surfactants can be 
removed from the interface via an orogenic displacement mechanism by bile salts. v)Micelles 
of bile salt and phospholipid can also remove surface-active lipolysis product from the 
interface for further absorption in the intestinal phase. Diagram was adapted from Golding et 
al. (2010). Reproduce with permission from Elsevier. 
The process of lipid digestion and absorption is shown in Figure 2.6. Bile salts and 
phospholipids secreted by the liver are particularly crucial for lipid digestion in the 
intestine (Bauer, Jakob, & Mosenthin, 2005), as bile salts have amphiphilic properties 
and act as a detergent. They have a planar structure with a steroidal nucleus for 
hydrophobic side, and a few hydroxyl groups and an ionic head forming the hydrophilic 
side (Bauer et al., 2005; McMurry, Hoeger, Ballantine, & Peterson, 2012). Bile salts can 
facilitate lipid digestion through two different mechanisms. Firstly, when the 
concentration of bile salts is above their critical micellar concentration (CMC, 2-4 mM), 
bile salts can displace some surfactants such as Tween 80 which is an inhibitor to HPL, 
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and allow the complex of HPL and co-lipase binding on the oil/water interface (Gargouri 
et al., 1983).  Secondly, when products of lipolysis such as monoglycerides and free fatty 
acids accumulate at the interface, those products can prevent the complex of HPL and co-
lipase from binding onto the oil/water interface (Pafumi et al., 2002). Bile salts can also 
emulsify and incorporate these lipolysis products from the interface into mixed micelles 
and the aqueous phase (Golding & Wooster, 2010; Lentle & Janssen, 2011; Mu & Hoy, 
2004; Porter, Trevaskis, & Charman, 2007). 
As stated earlier, the concentration of digestive enzymes, especially pancreatic lipase, is 
significantly lower in preterm and full-term infants compared to children and adults 
(Lebenthal & Lee, 1980). Also, the secretion of bile salt phospholipids postprandially in 
both neonates and full-term infants is lower than that in adults. Overall the concentrations 
may be insufficient for efficient lipolysis (Table 2.1). Alternative pathways, as mentioned 
in the previous section, such as gastric lipase, and the additional contribution of lipases 
present in maternal milk, such as bile salt stimulated lipase (BSSL), may support lipid 
digestion and absorption. However, the relative value of these contributions is still not 
fully determined. 
1.1.1.1 Bile salt stimulated lipase 
Bile salt stimulated lipase (BSSL) is an external lipase which is considered as one of the 
most important lipolytic enzymes for infant lipid digestion. It is secreted with human 
breast milk from the mammary gland (Hernell & Olivecrona, 1974a, 1974b). BSSL is 
also secreted from the acinar cells of the pancreas in the neonates and the expression in 
fetal tissues is as early as the 6 weeks of gestation (Roudani, Miralles, Margotat, 
Escribano, & Lombardo, 1995). BSSL is a highly glycosylated enzyme with a molecular 
weight of 107,000 Da (Hansson et al., 1993; Landberg et al., 2000). It is a nonspecific 
lipolytic enzyme which hydrolyses not only triglycerides, diglycerides and 
monoglycerides but also cholesteryl esters, phospholipids, lysophospholipids, and 
ceramide (Hui & Howles, 2002). Similar as human gastric lipase, lipolysis by BSSL in 
human milk is considered to have an important contribution to the total lipid digestion in 
the neonates (Bernback, Blackberg, & Hernell, 1990; Roman et al., 2007). BSSL cannot 
hydrolyse lipids from human milk fat globule alone, and it remains stable (cannot be 
hydrolysed by pepsin) and inactive within the pH range of the neonatal gastric 
environment (Armand, Hamosh, et al., 1996; Bourlieu et al., 2014). It does not hydrolyse 
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lipids in human milk until reaching the duodenum, being activated by bile salts (Hernell 
& Bläckberg, 1994). The mechanism of this process is not well understood. In an in vitro 
test, hydrolysis of more than 90% of human milk triglycerides could be achieved with the 
combined work of pancreatic lipase, colipase and BSSL (Bernback et al., 1990; Hernell 
& Bläckberg, 1994). The optimum pH range of BSSL is from 7.4 to 8.5 (Hamosh, 2001). 
Its activity in preterm and term human milk ranges from 25 to 30 U/mL and remains 
constant within the length of lactation (Mehta, Jones, & Hamosh, 1982). 
2.3 Human breast milk and infant formula 
2.3.1 History of infant formula 
In the early ages, before artificial infant foods appeared, wet nurses who fed other 
mother’s children were very common (Stevens, Patrick, & Pickler, 2009). Starting from 
the 16th century, liquid substitutes such as pap (bread soaked with water or milk) and 
panada (cereals cooked in broths) appeared in the cities in Europe (Radbill, 1981; Wickes, 
1953). Animal milk such as cow and sheep milk were also alternatives for human breast 
milk. However, many of the alternatives raised hygiene and health problems, which 
increased malnutrition and mortality rates among the newborns (Kleinman, Barness, & 
Finberg, 2003; Wegman, 2001). In the mid-19th century, German chemist Justus von 
Liebig produced the first liquid infant formula based on bovine milk, with wheat with 
addition of malt flour and potassium bicarbonate. Nestlé formulated the first powder 
infant formula (Schuman, 2003), and many brands of infant formulae became 
commercially available afterwards (Bracken, 1953). 
From the beginning of the 20th century, researchers started to understand the critical 
components of mammal-originated milk, and manufacturers used different approaches to 
improve infant formula. In the early 20th century, skim milk (without fat) was used to 
avoid short-chain fatty acids found in bovine milk, which were believed not to be 
tolerated by infants (Fomon, 2001; Gerstenberger, Ruh, Brickman, Leslie, & Ochsner, 
1919). The manufacturers increased protein level as people believed that the protein 
content in the human breast milk was much higher than the actual value (Fomon, 1967, 
2001). In general, formula milk at that stage were either evaporated milk with added 
vitamins or low protein milk with added oleic oils, vitamins and minerals (Wargo, 2016). 
In the late 20th century, formula with similar casein/whey ratio to human milk was 
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developed in the United States, and this added-whey formula became a predominant 
formula type in the 1990s (Fomon, 2001). Fortified infant formula was developed at a 
later stage, with added polyunsaturated fatty acids, probiotics, taurine and nucleotides to 
support healthy growth and enhanced immune system (Schuman, 2003; Wargo, 2016). 
From the 1960s and onwards, infant formulae have gradually become what they are today, 
by using ingredients that can improve growth and development of the neonates such as 
galacto-oligosaccharides (GOS), unsaturated fatty acids, probiotics. With further 
developments in the contemporary days, companies in this industry have improved their 
formulae by adding compounds such as docosahexaenoic acid (DHA) to improve the fat 
composition and facilitate cognitive and brain development and membrane fragments of 
the bovine milk fat globules to improve growth and development for infants at early ages. 
2.3.2 The droplet structure of human breast milk and infant formula 
2.3.2.1 Human milk 
Lipids in human milk are packed as fat globules, secreted directly from the epithelial cells 
of the mammary glands. Hence, these triglyceride cores are surrounded by a tri-layered 
membrane structure composed of polar lipids, proteins, enzymes, cholesterol and 
glycoproteins (Jensen et al., 1995a).  The tri-layered structure results from the 
combination of an inner mono-layer derived from the endoplasmic reticulum and an outer 
bilayer derived from the apical plasma membrane of the mammary epithelial cells 
(Keenan & Patton, 1995; Lopez, 2011; Lopez & Menard, 2011). The tri-layer membrane, 
known as the milk fat globule membrane (MFGM) that envelopes the lipid core. 
A structural model (Figure 2.7) of the human milk fat globule membrane (MFGM) 
proposed by Lopez & Menard (2011) postulated that two lipid phases coexist in the outer 
bi-layer of the MFGM – the liquid-ordered (Lo) phase and the liquid-disordered (Ld) phase 
where the tri-layer of polar lipids acts as the backbone. These two lipid phases have the 
same fluid symmetry but a different degree of acyl chain order (Ipsen, Karlström, 
Mourtisen, Wennerström, & Zuckermann, 1987; Mouritsen, 2010). The liquid-disordered 
(Ld) phase is a fluid (liquid-crystalline) phase (Ipsen, Mouritsen, & Bloom, 1990) whereas 
the liquid-ordered (Lo) phase exists between a gel and a fluid phase with a tight packing 
and relatively extended acyl chains (Mouritsen, 2010). The Ld phase domain consists of 
glycerophospholipids—phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
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phosphatidylserine (PS) and phosphatidylinositol (PI) and it is surrounded by Lo phase 
domains enriched of sphingomyelin (SM) and cholesterol. In the (SM-rich) L0 domain, 
this phase could be symmetrically orientated across the two leaflets of the MFGM bi-
layer, or asymmetrically placed in the outer layer of the bi-layer. Cholesterol could fill 
the space between the polar head groups (phosphocholine and ceramide, or 
phosphoethanolamine) of SM locally increasing the thickness of MFGM. The 
glycoproteins and glycolipids are randomly distributed in the external surface of MFGM. 
 
Figure 2.7 A model structure of the human MFGM. The schematic presentation showed the tri-
layer of the MFGM, with the polar lipid backbone and the lateral view of the plane of bi-layer 
organisation consisted of phase-separated Lo domain (rich in sphingomyelin) and Ld domain 
(glycerophospholipids) with proteins bound to the periphery of the Ld domain. Adapted from 
Lopez et al. (2011). 
This particular structure of MFGM at the interface stabilises the milk fat during the short 
period of expression to digestion. The structure composed of phospholipids and a group 
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of glycoprotein filaments in the outer layer of MFGM may facilitate sufficient digestive 
lipase binding and adsorption to achieve hydrolysis of the triglycerides core and lipid 
absorption (Hamosh et al., 1999; Jensen, Ferris, & Lammi-Keefe, 1992; Lopez & Menard, 
2011). 
2.3.2.2 Infant formulae 
The structure of the oil droplets in infant formulae depends on the ingredients in milk, i.e. 
proteins, fat and carbohydrate content, and the composition of the interface and the 
processing methods. Also, the interface relies on the presence of surface-active 
ingredients in the formulation, mainly proteins and phospholipids, which will partition 
across the oil/water interface depending upon the degree of hydrophobicity and the 
distribution of polar groups. A schematic presentation of the oil droplet in infant formula 
based on this description is shown in Figure 2.8. 
 
Figure 2.8 An assumed structure of infant formula oil droplet depends on ingredients and 
process. 
Adsorption of proteins and emulsifiers provides a physical barrier for oil droplets and 
particularly proteins prevent them from coalescence, still providing enough interface for 
lipase binding and action.  However, the interfacial composition may vary depending on 
the competition between milk proteins and the more surface-active emulsifiers like 
monoglycerides and phospholipids at the interface of fat droplets in infant formula 
(McSweeney, Healy, & Mulvihill, 2008; Wilde, Mackie, Husband, Gunning, & Morris, 
2004). Lipase has a different affinity for different interfacial layers. Thus the interfacial 
composition and characteristics of the emulsion droplet are very likely to influence the 
adsorption and activity of digestive lipase (Hur, Decker, & McClements, 2009). 
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For both human milk and infant formulae, the stability and properties of the interface of 
the fat globules are influenced by the physiochemical environment of the GI tract. The 
conditions may change when digestion processes, and therefore, the rate of lipolysis may 
change accordingly. 
2.3.2.3 Droplet sizes in human breast milk and infant formulae 
The average size of human breast milk fat globule is shown in Figure 2.9. The volume 
surface-weighted mean diameter (d32) ranges from 1.5 to 2.1 µm where the volume 
moment-weighted mean (d43) ranges from 2.5 to 4.6 µm depending on the milk source 
(Huppertz & Kelly, 2006). The oil droplet size in infant formulae is much smaller, always 
below 1 µm for d32 values (Table 2.5). The size distribution of two infant formulas is 
shown in Figure 2.9. 
Table 2.2 A comparison of the droplet properties of fat globules from different infant milk 
sources. 
Parameters Mature human milk* Infant formula 
d32 (µm) 
3.5 ± 0.1a; 
4.0 ± 0.3b 
0.3 ± 0.0a; 
0.8 - 1.1c 
d43 (µm) 
4.4 ± 0.2a; 
5.2 ± 0.4b 
2.0 ± 0.9a 
Surface (dm2/mL) 6.7 ± 0.3d 
64 ± 9a; 
20c 
Specific surface area (m2/g) 1.9±0.1a; 1.4±0.1a 
22.1±1.7a; 
5.2~7.2c 
Natural surface charge 
(mV) 
-20e -33 - -38e 
This table was adapted from Michalski et al. (Michalski, Briard, Michel, Tasson, & Poulain, 2005). 
Reproduce with permission from Elsevier. 
*Sampled from 5 mothers (Lueamsaisuk, 2015). 
aData collected from Michalski (Michalski et al., 2005). 
bData collected from Rüegg (Rüegg & Blanc, 1981). 
cData collected from Simonin (Simonin, Rüegg, & Sidiropoulos, 1984). 
dThe fat content in mature human milk was considered as 35 g/L. 





Figure 2.9 Droplet size distribution of several milk samples, including maternal milk and some 
infant formulae (Lueamsaisuk, 2015). Reproduce with permission from Lueamsaisuk. 
Due to the high-pressure homogenization during the production of infant formula, the oil 
droplets always present a smaller droplet size and consequently larger surface area (64±9 
dm2/mL) than in human milk (6.7±0.3 dm2/mL). Hypothetically, lipid components in 
infant formulae would be more efficiently digested than in human milk if digestion was 
only dependent upon the surface area available for lipase binding. However, it has been 
shown that the oil droplets in human milk are digested more rapidly than in infant formula 
(Armand, Hamosh, et al., 1996). This is most likely due to the different membrane 
structure in the fat globule of human milk compared to infant formulae, with the latter 
presenting a protein layer at the oil/water interface which may be bound to affect the 
action of lipase. 
2.3.3 The composition of human milk and infant formulae 
Human milk provides essential nutrients and growth factors for infants. Infant formula as 
a supplement or replacement for human milk, therefore, needs to provide equivalent 
nutritional value to that of human milk. Production of milk, either via secretion from the 
mammary glands or through the processing of the infant formula invariably leads to 
differences between the two types of milk, not only in composition, nutritional value and 
immune functions but also in oil droplet size and globule structure.  These differences are 
believed to play an essential part in lipid digestion, growth and development of infants. 
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A comparison between the main nutrient components of human milk and infant formula 
is shown in Table 2.3. 
Table 2.3 The Composition of human milk and infant formula in the percentage of the total 
components. Reproduce with permission from Elsevier. 
Components Human milk (%) Infant formula (%) 
Protein 1.0 1.5 
Whey/Casein 70/30 60/40 
Fat 3.8 3.8 
Lactose 7.0 7.2 
Total solids 12.0 13.0 
Ash 0.2 0.3 
This table was adapted from Guo et al. (2013). 
Lipids contribute about 4% of the human milk volume (Jensen, 1996). Of these, 
triglycerides make up for about 98%, with phospholipids accounting for 0.7%, cholesterol 
for 0.5% and with the presentation of a small amount of lipolytic products (Koletzko et 
al., 2001). The lipid content of human milk varies to some extent between individuals and 
with diet, as does protein and lactose, though to a lesser extent. Other carbohydrates in 
human milk such as oligosaccharides are significant micronutrients that usually consist 
of approximately 1 g/100 mL depending on the stage of lactation and other factors 
(Ballard & Morrow, 2013). Lipid composition in infant formula is relatively invariant 
although there are some differences between manufactures. The lipids in infant formula 
also consist mainly of triglycerides, some phospholipids, lecithins and small quantities of 
monoglycerides as emulsifiers to stabilise the emulsion and as wetting agents for power 
formulations. 
The profile of the primary fatty acids in triglycerides in human milk differs from that of 
infant formula (Table 2.4). In human milk, saturated fatty acids account for a significant 
part of the total fatty acids in the triglycerides, with palmitic acid accounting for a large 
part of the saturated fatty acids. The mono-unsaturated fatty acids, such as oleic acid (18:1) 
and polyunsaturated fatty acids such as linoleic acid (18:2) constitute the highest 
proportion of the unsaturated fatty acids. The amount of long-chain polyunsaturated fatty 
acids such as docosahexaenoic (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) 
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have significant nutritional value and vary with the maternal diet (Innis, 1991; Innis & 
Kuhnlein, 1988). Hence, deficient intake of DHA and ARA may lead to decreased visual 
and brain development of the new-borns (Innis, 2004; Innis, 2007; Uauy, Hoffman, Mena, 
Llanos, & Birch, 2003). 
Table 2.4 The fatty acid content from human milk compared to that from infant formulae (% of 
the total fatty acids). 
Fatty acids Abbreviations Human milk Infant formula 
Saturated    
Caprylic C8:0 - 1.3 (0.7-1.5) 
Capric C10:0 1.4 (1.2-1.6) 1.1 (0.9-1.3) 
Laurie C12:0 5.4 (4.4-6.0) 9.4 (6.6-12.1) 
Myristic C14:0 7.3 (6.9-7.9) 4.9 (4.3-6.6) 
Palmitic C16:0 26.5 (26.0-27.0) 20.0 (14.0-26.3) 
Stearic C18:0 9.5 (8.5-10.5) 4.9 (3.6-7.5) 
Unsaturated    
Palmitoleic C16:1 4.0 (3.7-4.2) 0.4 (0.1-1.1) 
Oleic C18:1 35.5 (34.5-36.0) 40.6 (28.7-53.0) 
Eicosaenoic C20:1 0.5 (0.5-0.6) 0.3 (0.2-0.5) 
Linoleic C18:2 (n-6) 7.2 (6.4-7.7) 12.4 (8.8-18.9) 
-linolenic C18:3 (n-3) 0.8 (0.7-0.9) 1.5 (0.7-2.2) 
This table was adapted from Wells (1996). Reproduce with permission from Elsevier. 
About 60% of the palmitic acid (16:0) is located on the sn-2 position in human milk fat, 
with the major portion of lauric (12:0) and oleic acids (18:0) located at either the sn-3 or 
sn-1 positions. Similarly, the bulk of linoleic (18:1) and -linolenic (18:2) acid are located 
at the sn-1 and sn-3 position (Jensen et al., 1995b; Koletzko et al., 2001; Thureen, 2006). 
The molecular structure of triglycerides is important as the digestive lipases only 
hydrolyse the sn-3 or sn-1 and sn-3 positions. If palmitic acid is positioned at the sn-3 or 
sn-1 position, the released palmitic acid by digestive lipases could interact with cations 
such as calcium, which forms insoluble soaps that are not available for absorption (López-
López et al., 2001). Palmitic acid located at the sn-2 position could form monoglycerides 
that are better suited for the formation of mixed micelles and increase the availability of 
palmitic acid, facilitating absorption through the intestinal wall. Compare to infant 
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formulae where most of the palmitic acids are located at the sn-1 or sn-3 positions, 
palmitic acids in human milk have shown better absorption when they are esterified at 
the sn-2 positions as proved by clinical trials (Carnielli et al., 1995; Carnielli et al., 1996). 
Triglycerides in infant formulae usually come from a blend of two or three vegetable oils 
such as sunflower oil, palm, coconut, soy and canola oils (Lueamsaisuk, 2015; Talbot, 
2015). The use of different proportions of vegetable oils can mimic some aspects of the 
fatty acid profile found in human milk fat. While formulae can be improved in this way, 
it is challenging to imitate the proportion of all 160 kinds of fatty acids (Jensen, Hagerty, 
& McMahon, 1978; Thureen, 2006) that are known to be present in human milk. Coconut 
oil provides a rich source of short-chain saturated fatty acids such as lauric (12:0) and 
myristic acids (14:0), while palm oil is a rich source of the palmitic acid (16:0) (Packard, 
2012; Prosser, Svetashev, Vyssotski, & Lowry, 2010; Talbot, 2015). However, as stated 
above, palmitic acids in vegetable oils are usually located at sn-1 and sn-3 positions, 
unlike in human milk they are located at the sn-2 positions. Also, different from vegetable 
oils, palmitic acids in human milk account for 20-25% of the total fatty acids (Xu & Akoh, 
2002) with most of them positioned at the sn-2 positions. Palmitic acids from human milk 
can be absorbed better than from infant formulae in infants, as already mentioned. In 
order to change the palmitic acid position in the vegetable oils, some speciality fat such 
as Betapol that are developed by enzyme technology to better mimic human milk fat and 
increase the intake of palmitic acids (Talbot, 2015; Xu & Akoh, 2002). Safflower, 
sunflower, soybean oil and corn oil are excellent sources for mono and polyunsaturated 
fatty acids (Thureen, 2006). Soybean oil and linseed oil are good sources of -linolenic 
acid and fish oil a good source of docosahexaenoic acid (DHA) and EPA 
(eicosapentaenoic acid) (Talbot, 2015). As DHA and arachidonic acid (ARA) presented 
in maternal milk are essential for the development of cognitive, vision and immune 
function for infants, the European Food Safety Authority has recommended providing 
adequate supply for DHA and ARA in infant formulae (EFSA Panel on Dietetic Products 
& Allergies, 2013; Lien, Richard, & Hoffman, 2018). 
The membrane of fat droplets in human milk consists of phosphatidylcholine, 
phosphatidylserine, phosphatidylinositol, sphingomyelin and glycosphingolipids such as 
gangliosides (Jensen et al., 1995a). Though these complex lipids are not the main energy 
source, they are important for infant growth, cognitive and neuro-development 
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(Dewettinck et al., 2008; Gurnida, Rowan, Idjradinata, Muchtadi, & Sekarwana, 2012; 
Motouri et al., 2003; Timby, Domellöf, Hernell, Lönnerdal, & Domellöf, 2014). These 
lipids also protect infants against pathogen infections (Dewettinck et al., 2008; German, 
Dillard, & Ward, 2002; Hamosh et al., 1999; Lopez & Menard, 2011). Infant formulae 
usually contain only trace quantities of membrane fractions that come from ingredients 
such as milk powder. The lack of MFGM in infant formulae is an important difference 
that distinguishes infant formulae from maternal milk. Accordingly, the functional roles 
and benefits of complex lipids are areas of increasing interest to the formula industry. 
Human milk protein comprises approximately 1% of the total milk volume, decreasing 
slightly between different lactation periods (Hendricks & Guo, 2014). The whey/casein 
ratio in human milk changes from 90/10 in early lactation to 60/40 in mature milk and 
50/50 in late lactation (Kunz & Lönnerdal, 1992). The main whey proteins consist of α-
lactalbumin, lactoferrin and secretory IgA (SIgA). In human breast milk, no β-
lactoglobulin is present, α-lactalbumin which accounts for about 40% of the whey and 17 
- 28% of the total protein dominates in human milk, whereas in bovine milk the level of 
this protein is only 3-3.5% (Heine, Klein, & Reeds, 1991; Thao, Bhesh, Cichero, & 
Sangeeta, 2015). Casein in human milk is in a micellar form comprising largely of β-
casein, κ-casein and a small amount of αS1-casein (Lönnerdal, 1985, 2016a). Other 
important proteins including lysozyme, folate-binding protein, bifidus factor, lipase, 
amylase, and haptocorrin (Hendricks & Guo, 2014) provide good sources of amino acids 
for infant growth and development. Many enzymes in human milk facilitate the digestion 
of lipids and starch. Human breast milk also contains proteins such as immunoglobulins, 
lactoferrin, lysozyme and κ-casein that provide a barrier and defence for infants from 
being infected by pathogenic bacteria, viruses and yeasts (Hendricks & Guo, 2014; 
Lönnerdal, 2003). 
The proteins in infant formulae may come from various animal sources such as bovine or 
goat milk, or vegetable sources such as soy or rice. Those proteins have an appropriate 
balance between lactalbumin and casein and provide a source of amino acids (Packard, 
2012), but do not adequately simulate human milk proteins. In order to meet the 
requirements of essential amino acids, Skim milk powder, whey protein concentrate 
powder and demineralised whey protein powder are commonly used instead of milk 
powder.  Moreover, in order to match the whey/casein ratio in maternal milk, infant 
formulae usually use whey-based milk, consisting of demineralised whey and skim milk 
25 
 
to achieve a whey/casein ratio of 60/40 (Hileti-Telfer, 2003). Finally, human milk also 
provides bioactive proteins such as lactoferrin that acts as intact proteins can prevent 
infants from infection. Lactoferrin from bovine has also been added as a supplementary 
component in infant formulae (Tomita, Wakabayashi, Yamauchi, Teraguchi, & 
Hayasawa, 2002). Some other bioactive proteins such as α-lactalbumin and osteopontin 
which form bioactive peptides during digestion may lead to an enhancement of the 
immune system and provide some other health benefits (Lönnerdal, 2016a, 2016b). 
2.4 In vitro and in vivo approaches for digestion studies 
In order to understand the digestion process, scientific studies usually use in vitro and in 
vivo approaches to collect data. Compared to in vitro studies, the in vivo approach—which 
is based on human and aminal trials—is usually a more representative way to understand 
digestion. However, studying this process is technically challenging and costly in human 
or aminal subjects, as this requires sufficient numbers of participants to ensure statistical 
relevance. For ethical reasons, it is even more difficult to conduct human trials in infants. 
Therefore, scientists in the past few decades have developed many in vitro models to 
roughly imitate the process of digestion. However, there are several problems with these 
simulations. Firstly, the digestive process is highly complex in nature and researchers still 
have not gained a comprehensive understanding of the physiology of digestion. This 
means that the in vitro models cannot properly simulate this process, and therefore, these 
models may not lead to physiologically relevant outcomes from lipid digestion in human 
subjects. Thus studies through an in vivo approach are ultimately needed correspondingly 
in order to verify findings through the in vitro approach. Secondly, the enzymes used in 
the in vitro models are not usually from human subjects because human digestive 
enzymes are not always available, and the cost is usually very high. Alternatives from 
other sources like animals and fungi may not have the same affinity, optimal pH range 
and activity to the substrates compared to those from human origin. Hence the results 
obtained from these in vitro studies could hardly explain what happens in vivo. Thirdly, 
the physiological forces in the human GI tract are complex and challenging to simulate. 
Many in vitro models have failed to apply the appropriate mechanical forces to simulated 
digestion with physiological relevance. Furthermore, most of the in vitro models are adult 
models and not designed specifically for infant studies. The digestive conditions of 
infants differ from that of adults and especially for lipid digestion, the lack of pancreatic 
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lipase and bile salts in the neonates suggests that lipid digestion in the gastric phase may 
be more critical than in the small intestine. However, only a few in vitro models have 
considered gastric lipid digestion (Ménard et al., 2014; Ménard, Picque, & Dupont, 2015). 
Besides, the BSSL in human milk may also play an essential role in neonatal lipid 
digestion. However, the role of BSSL in the neonatal lipid digestion has only been 
included in several in vitro models (Bernback et al., 1990; Chen, Bläckberg, Nilsson, 
Sternby, & Hernell, 1994) and those models hardly have adequate physiological 
relevance. Although in vitro models always have limitations as such, studies still need the 
in vitro approach to understand digestion in the GI tract for their lower cost compared to 
human trials and convenience to conduct experiments. 
In considering gastric digestion, food introduced to the stomach is influenced by several 
biophysical and biochemical conditions, such as the mechanical forces, the dynamic pH 
levels, and the production of digestive enzymes and salts. For in vitro analysis, any 
parameters are usually chosen for the model and can additionally be tailored to answer 
specific digestive questions. The following parts will give more details on the simulation 
of gastric digestion, and the appropriate selection and application of the varying 
parameters. 
2.4.1 pH level 
The pH profile for infant gastric digestion is markedly different from that in adults 
(mentioned in Chapter 2.2.1). Though it is possible to simulate the dynamic profile of the 
changing pH during gastric digestion, the results are challenging to interpret for that it is 
difficult to know what stage it stands for the entire process of digestion. Therefore most 
of the static in vitro models have selected fixed pH levels which are representative of the 
gastric environment at different phases, for example, at fasting or postprandial phase 
(Gallier et al., 2012; Golding et al., 2011; Lueamsaisuk, Lentle, MacGibbon, Matia-
Merino, & Golding, 2014). The advantage of a fixed pH level for in vitro tests is that it is 
relatively easy to study the influences from other parameters. However, it only provides 
physiological relevance for a specific window of digestion. The main problem arises from 
the fact that most of the studies use their own in vitro models, making the results very 
difficult to compare with each other. 
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Some semi-dynamic or dynamic models have been developed to simulate the secretion 
of gastric content and the dynamic pH profile by gradually adding hydrochloric acid into 
the system which follows a predetermined curve relevant to physiological conditions 
(Guerra et al., 2012; Kong & Singh, 2010; Minekus, 2015). A dynamic model that 
simulates infant digestion has been recently developed with adjustment of parameters 
considering physiological aspects of the GI tract in infant (Ménard et al., 2014). The 
volume adjustment in this study through acid addition can dilute the mixture, and 
therefore influencing sampling. For the development of infant gastric in vitro models, the 
pH profile is largely affected by the buffering effect of the ingested milk and the 
frequency of feeding. This, in return, influences the concentration and activity of the 
digestive enzymes. 
2.4.2 Digestive enzymes used in in vitro digestive systems 
Enzymes used in in vitro models for human digestion are usually selected from animals 
or microbial sources, rather than using the extracts from the stomach or small intestine 
from human subjects due to their costs, accessibility and the challenges of standardising 
the extracted materials. Human gastric pepsin and lipase are the main digestive enzymes 
that would need to be used in gastric in vitro studies. Human gastric pepsin shows optimal 
activity at pH 2. It is stable in the acidic gastric environment until pH reaches 6, where 
the activity starts to drop off. In vitro studies usually use porcine pepsin because of its 
low cost and commercial availability. The optimal pH range for the activity of this porcine 
pepsin is from 1.5 to 2.5, which is close to that of human gastric pepsin. Porcine pepsin 
is widely used as a substitute for human gastric pepsin. They are commercially available 
and relatively more stable than human pepsin with known activity. A variety of pepsin 
concentrations from 0.4 mg/mL to 5 mg/mL with activity from 800 to 2500 U/mg have 
been used in previous studies (Gallier et al., 2012; Golding et al., 2011; Minekus et al., 
2014; Ruby et al., 1993; Sarkar, Goh, & Singh, 2009; C. Versantvoort & Rompelberg, 
2004; C. H. Versantvoort, Oomen, Van de Kamp, Rompelberg, & Sips, 2005). 
The use of gastric lipase in the in vitro models is very challenging. Some early in vitro 
studies omitted gastric lipase entirely, while others usually applied lipases from 
uncommonly-used sources rather than from porcine or human subjects (Golding et al., 
2011; Hur, Lim, Decker, & McClements, 2011; Lueamsaisuk et al., 2014). In terms of 
finding appropriate analogues for human gastric lipase with similar optimal pH range and 
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activity, while a few studies have indeed used human gastric extracts (Carrière et al., 1997; 
Garcia, Antona, Robert, Lopez, & Armand, 2014) as part of in vitro analysis, it is still 
very challenging to obtain extracts from human subjects because of their ethical 
restrictions, commercial availability and variability. Alternatives such as fungal lipase 
(Golding et al., 2011; Lueamsaisuk et al., 2014, 2015; Ménard et al., 2014), rabbit gastric 
lipase (Bourlieu et al., 2015; Capolino et al., 2011), dog gastric lipase (Vié et al., 2015) 
and calf pre-gastric lipase (Lueamsaisuk et al., 2014, 2015) have already been used for in 
vitro studies for lipid digestion. Some of these lipases from mammal origins (Table 2.5) 
with a relatively low optimal pH range could be treated as more appropriate analogues to 
HGL. 
Table 2.5. Stable and optimal pH ranges of selected lipases. 
lipase Stable pH range Optimal pH range 
Human gastric lipase 2 – 7a 3-6b 
Dog gastric lipase 1 – 2c 3.5-6.5c 
Rabbit gastric lipase 3 – 6c 4c 
Calf pre-gastric lipase 6.0 - 8.0d 6.5d 
Fungal lipase 4.5 - 7.5e 7.5e 
aData from Ville et al. (Ville et al., 2002). 
bData from Roussel et al., Gargouri et al., Ville et al., and Carriere et al. (Carriere et al., 1991; Gargouri, 
Sarda, et al., 1986; Roussel et al., 1999; Ville et al., 2002). 
cData from Carriere et al. (Carriere et al., 1991). 
dData from (Manuel, 1999). 
eData from (Hiol et al., 2000). 
Lipases from fungal or mammal origins usually have different stereo-specificity for 
triglycerides from human gastric lipase. For example, fungal lipases cleave the sn-1 and 
sn-3 positions, and lipases from mammal origins only cleave sn-1 or sn-3 position 
(Ménard et al., 2014; Rogalska, Cudrey, Ferrato, & Verger, 1993; Rogalska et al., 1990). 
Among those alternatives, some in vitro studies prefer to use fungal lipases from a 
selected strain Rhizopus oryzae (ATCC 1996) because of its stability under gastric 
conditions compared to lipases from mammal origins. Fungal lipases are widely used in 
the food industry. They are commercially available with a known amount of activity. The 
activity of fungal lipase from this selected strain has optimal activity at pH 7.5. It is stable 
at a pH 4.5-7.5 and hydrolyses triglycerides at their sn-1 and sn-3 positions (Hiol et al., 
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2000). Its optimum deviates from that of human gastric lipase (pH 3.0-6.0) (Hamosh et 
al., 1981; Roussel et al., 1999; Ville et al., 2002). Since after ingestion, gastric pH in 
infants is relative higher (5.2 to 7.1) than that in adults (where pH stays from 3.5 to 5.0), 
both fungal lipase and porcine pepsin may not achieve their optimal performance for in 
vitro tests under such pH range. Some studies have proposed that the optimal pH range 
may not reflect the local pKa in the vicinity of the active site of lipases with lid domains 
(Poulsen et al., 2005). For human gastric lipase, the lid domain of lipase needs to be 
shifted to expose its active site to the oil/water interface (Miled et al., 2003). Therefore, 
the pH at which the lid is activated between human gastric lipase and its alternatives also 
needs to be considered in simulated gastric digestive models. 
Table 2.6 A comparison between adult and infant simulated gastric systems. 
Parameters Infant Adult 
Meal : Simulated Gastric Fluid (v:v) 63:37 1:1 
Pepsin 
1250 U/mL 
Flow: 0.25 mL/min 
2,000 U/mL 
Lipase from rabbit or dog gastric extract 
60 U/mL 
Flow: 0.25 mL/min 
60 U/mL 
Incubation time (min) t1/2a = 70 120 
pH -0.011*tb + 5.4 3 
Temperature (ºC) 37 37 
Data in this table was from Ménard et al. (2018), Ménard et al. (2014), Minekus et al. (2014), Brodkorb 
et al. (2019). 
at is the time after ingestion, min. 
bt1/2 is the half time of delivery. 
A comparison of adult and infant simulated gastric model is shown in Table 2.6. The 
infant model refers to an in vitro dynamic system proposed by Ménard et al. (2014).   The 
adult model was a static system based on a standard method that uses enzymes from the 
same sources and at fixed concentrations. The gastric pH of the infant model has a 
dynamic pH profile and was much higher than that of the adult in general. In the digestion 
protocol proposed by the INFOGEST network (http://www.cost-infogest.eu) involving 
multidisciplinary experts from more than 35 countries was proposed in 2014 (Minekus et 
al., 2014), lipid digestion in the gastric phase was considered to have a minor influence 
on adult lipid digestion (as opposed to the greater role in infant digestion), therefore usage 
of gastric lipase in this static in vitro model has not been recommended. An update of this 
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protocol was published in 2019 by Brodkorb et al. (2019) has added a recommendation 
for involving gastric lipase in the static model together with the limitations of using 
gastric lipase. This method has also proposed one constant pH level (pH 3) for digestion 
as a basic suggestion. Since the gastric phase has a changing pH profile from fasting to 
the postprandial stage, it may only provide information for gastric digestion at a certain 
stage.  Furthermore, for both infant and adult model, there was not a recommended shear 
rate for in vitro digestion tests in the gastric phase, the deficiency of information on the 
shearing force may reduce physiological relevance of the model and add difficulties in 
understanding the effect of mechanical forces on the structure of lipid emulsions. 
2.4.3 Physical forces 
Replicating the mechanical environment in the stomach is also a critical consideration in 
developing physiologically relevant in vitro models. A series of contractions in the 
stomach assists in breaking down food components, mixing food with gastric juice and 
emptying gastric content (Johnson, 2014; D. J. McClements, Decker, & Park, 2009; 
Schulze, 2006; Schwizer, Steingoetter, & Fox, 2006). Contractions from the antrum and 
pylorus generate shearing forces to assist in the process of food mixing and breaking 
down. Studies by Lentle et al. (Lentle & Janssen, 2011; Lentle, Janssen, Goh, Chambers, 
& Hulls, 2010) have observed a maximum shear rate of approximately 0.7 s-1 in the 
gastric phase, as estimated from an ex vivo rat stomach, while the velocity of the gastric 
retropulsive jet has been calculated to be approximately 7.5 mm/s, based on the 
observations from human gastric models (Pal et al., 2004; Schulze, 2006). However, 
many in vitro models use a stirring rate of 100 rpm (or even higher) which generates much 
higher shear rates than 0.7 s-1. While this may ensure good mixing of samples, these shear 
rates are significantly higher than those was present in the physiological conditions of the 
human stomach. The application of elevated shear rates may be particularly problematic 
as it induces structural changes to ingested food that would not be expected to occur with 
low shearing forces applied for the digestive environment. This is particularly an issue 
for static models, where the common use of magnetic stirrers always provides a shear rate 
far above the physiological low shear rate due to their speed limitations. 
31 
 
2.4.4 Use of in vitro models 
The growing interest in the digestion process of foods has led to the development of many 
in vitro models capable of simulating digestion in the human GI tract. Static models are 
the most widely used approach not only for food materials but also for drug development. 
Static models usually have fixed parameters such as enzyme concentration, pH level, and 
ionic strength, and reactions take place in a thermostatically controlled vessel. Static 
models have been shown as a convenient means of investigating the influences of gastric 
conditions on lipid digestion separately (Golding et al., 2011; Lueamsaisuk et al., 2014; 
Minekus et al., 2014). However, the variability between model design and development 
of methods used to analyse the digestate has presented challenges in providing consistent 
information to prove their relevance to human physiology. An example of this particular 
concern is the determination of the extent of lipolysis during simulated lipid digestion, 
which is one of the most important links in understanding lipid digestion. Over the past 
few decades, the pH-stat method has been frequently used as an assay for lipolysis 
(Helbig, Silletti, Timmerman, Hamer, & Gruppen, 2012; Li, Hu, & McClements, 2011; 
D. J. McClements & Li, 2010; Mun, Decker, Park, Weiss, & McClements, 2006). The 
pH-stat method measures the amount of lipolysis product by titrating the liberated FFA 
with NaOH while keeping pH at a constant level (usually at pH 7). However, this titration 
method is more suitable for determining the degree of lipolysis under neutral small 
intestinal conditions rather than under acidic gastric conditions, as the pH endpoint of the 
digestate needs to be higher than the pKa of liberated fatty acids. Detection of the protons 
released from lipolysis requires ionisation of the liberated free fatty acids. Since pKa of 
these free fatty acids varies from 4.7 to 4.9 (D. J. McClements & Li, 2010), they are only 
in the ionised form at the neutral intestinal pH (5.8-6.8), where sodium hydroxide (NaOH) 
can neutralise the released protons and keep the pH level constant to the initial one. 
Sometimes digestion of lipids also involves breaking down of proteins. If proteolysis is 
taking place simultaneously, the generation of amino acids could also influence the 
accuracy of the method. This method also does not allow measurement of other lipolytic 
products such as mono- and di-glycerides. These surface-active compounds may change 
the properties of oil/water interface and in consequence, have an impact on the rate of 
lipolysis. Other methods such as gas chromatography (GC) and thin-layer 
chromatography (TLC) can be applied in combination with static models to determine 
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the types and quantities of the lipolytic products more precisely. Such measurements need 
to be made over the course of the digestion period. Thus, the combined method using pH-
stat and GC/TLC, or comparison between different methods may provide more powerful 
results than using the pH-stat alone. 
While static models are most commonly used to simulate digestion, many dynamic 
models have also been developed to monitor digestion in a simulated way, with 
considerations of stomach emptying, dynamic gastric pH profile and constant enzyme 
secretion (Ménard et al., 2014; Minekus, 2015). 
2.4.5 Validation of in vitro models 
Studies based on human clinical trials have allowed correlations to link between 
properties of emulsions and gastric function, plasma triglycerides concentration, hormone 
respond for satiety and food intake (Keogh et al., 2011; Marciani et al., 2009; Marciani 
et al., 2007; Oosting et al., 2014; Steingoetter et al., 2015), which validate the in vitro 
models used in many studies. Studying digestion through human models has always 
brought ethical issues and increased costs. This is particularly true for studies associated 
with infant digestion. Experiments conducted among premature infants may provide a 
pathway for in vivo investigation since they fed on naso- or orogastric tube, which 
facilitates data collecting (Armand, Hamosh, et al., 1996). However, in vivo studies 
conducted in healthy infants can be more challenging (Abrahamse et al., 2012). This is 
not only from an ethical perspective, other considerations, such as the rapidly changing 
digestive physiology of infants during the early stages of growth, means that human 
studies using infants can be challenging to implement. Therefore, animals are also 
commonly used in lipid digestion studies, particularly when considering neonatal 
digestion, with several options available, such as mini-pigs, rats, dogs and rabbits 
(Capolino et al., 2011; Gallier & Singh, 2012; Goncharova et al., 2014; Iverson, Kirk, 
Hamosh, & Newsome, 1991). However, digestion in the animals differs significantly 
from that of human, which means the results obtained and conclusions drawn from the 
animal models may not be valid in humans. Developing proper methods for in vivo and 
in vitro correlations will provide robust findings for us to understand the real physiology 
of digestion in the GI tract. 
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2.5 Factors influencing the stability of infant milk emulsions 
during gastric digestion 
Many factors in the gastric environment influence the stability of milk emulsions such as 
pH level, digestive enzymes, ionic force, and physical forces as well as the physical 
characteristics of the milk emulsions. The following sections will discuss some of the 
most important features that influence the colloidal status of milk emulsions in the gastric 
phase. 
2.5.1 The impact of gastric pH on interfacial properties 
Gastric pH can influence the stability of emulsions as it changes from fasting to 
postprandial states. The pH profile of the fasting states in the adult human is 1.7-2.9 
(Armand, Borel, et al., 1996a; Armand et al., 1999; Dressman et al., 1990; Kenmogne-
Domguia, Meynier, Viau, Llamas, & Genot, 2012; Lindahl, Ungell, Knutson, & 
Lennernäs, 1997) which differs very much from that of the neonates (pH 3.5) (Chatterton 
et al., 2004; Mason, 1962). In the gastric environment, the postprandial pH level in 
healthy infants usually varies from 3.5 to 6.7 (Mason, 1962; Mitchell et al., 2001), 
whereas in adults, it remains at 4.0-6.7 (Armand, Borel, et al., 1996a; Armand et al., 1999; 
Dressman et al., 1990; Kenmogne-Domguia et al., 2012; Lindahl et al., 1997). 
After ingestion, the milder acidic neonatal gastric environment in infants plus the 
buffering effect of infant milk (breast milk or infant formulae) will bring gastric pH close 
to neutral. As digestion proceeds, the dropping pH level transits through the isoelectric 
point of proteins at the interface (usually between 4 and 5) (Law & Leaver, 2000; Walstra, 
1999). At that pH range, the electrostatic repulsion is reduced— the absolute ζ-potential 
values much lower than -20 mV (towards 0 mV) (Lentle & Janssen, 2011), which is not 
enough to stabilise milk emulsions by electrostatic repulsive forces, so the aggregation of 
proteins and the emulsion droplets happens. 
Maldonado et al. (2009) have used native β-lactoglobulin to form a film at the air/water 
interface to study the effect of physiological conditions on interfacial properties in the 
gastric phase. They found that under acid pH conditions, the dilatational and surface shear 
modulus had reduced. When the temperature increased to body temperature (37 °C), there 
was also a decrease in dilatational response and increase in surface pressure (Mellema & 
Isenbart, 2004). Therefore, the combined effect of low pH and body temperature could 
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weaken the network of interfacial proteins. However, if β-lactoglobulin was heated to 
above 60-80 ºC (as it would happen when processing protein-stabilised emulsions), the 
unfolding of its native form occurs, leading to the denaturation of the protein molecules 
(Eric Dickinson, 2010). The denaturation exposes more hydrophobic domains to the 
oil/water interface, thus increasing protein-protein interactions and therefore increasing 
the interfacial shear elasticity and viscosity of the interfacial protein layer at pH 5.5 and 
7. This added resistance to the interfacial protein network at the oil/water interface might 
decrease the propensity for the coalescence in the emulsions to some degree (Kim, Cornec, 
& Narsimhan, 2005). Clearly, the interfacial properties of β-lactoglobulin were sensitive 
to heat treatment before or after emulsification (Eric Dickinson, 2010; Raikos, 2010). On 
the other hand, interfacial layers made up of caseins such as β-casein at the oil/water 
interface, where the hydrophobic domains attached to the oil/water interface and the N-
terminal hydrophilic tail pocks into the aqueous phase (Eric Dickinson, 2001, 2010), are 
resistant to heating process but highly sensitive to pH as well as ionic strength (Eric 
Dickinson, 2010; E. Dickinson, Valerie, David, & Frans, 1997). 
Raw milk can aggregate at acidic gastric pH because of changes in the electrostatic 
repulsion of milk proteins as well as milk fat globules in the aqueous phase (Garcia et al., 
2014). An in vitro study has shown that after mixing, the surface-area mean diameter (d32) 
of fat globules in raw bovine milk with simulated gastric juice (pH 1.2), increased by a 
factor of 25 and the volume mean diameter (d43) increased by a factor of 10 because the 
milk fat globules were trapped into the aggregates formed with whey proteins and caseins 
(Gallier et al., 2012). Gallier et al. (2013) also confirmed an increase in the size of the fat 
globules under gastric conditions in a rat study. However, a study by Lueamsaisuik et al. 
(2015) observed no significant changes in droplet size distribution for human milk fat 
globules at pH 3.5, 4.5 and 5.5 under gastric conditions in a simulated neonatal model. 
The colloidal stability of native milk fat globules depends on three forces: Van der Waals 
forces, electrostatic interactions and repulsive steric forces (Huppertz & Kelly, 2006). 
The electrostatic repulsion is provided by the charges on the milk fat globule membrane, 
and the steric repulsion provided by glycoproteins on the membrane surface give counter 
forces to the Van der Waals attractions—which depend on droplet distance, size and other 
physical properties of the fat globules (Bergenståhl & Claesson, 1997; Friberg, 1997; 
Huppertz & Kelly, 2006; David Julian McClements, 2015). When Van der Waals 
attraction is stronger than the two other repulsive forces, aggregation occurs. The 
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electrostatic repulsion is mostly affected by the changing pH in the gastric phase as well 
as the presence of salts. In the gastric environment, the dropping pH decreases the charges 
of the milk fat globule membrane (Garcia et al., 2014) promoting aggregation. This 
destabilisation process reduces the effective interfacial area for lipase adsorption and 
therefore, may indirectly affect the rate and extent of gastric lipolysis. 
2.5.2 Proteolysis  
Proteolysis of the interface in protein-stabilised emulsions can change the interfacial 
properties and reduce the protein layer thickness, thereby inducing emulsion instability. 
The major forms of aggregation in protein-stabilised emulsions are flocculation, 
coalescence and partial coalescence (Huppertz & Kelly, 2006). When proteins adsorb at 
the oil/water interface, the electrostatic and steric repulsions provided by this polymer 
layer, protect droplets against flocculation and coalescence (Golding, 2013). Gastric 
proteolysis can cleave the hydrophilic domains and leave hydrophobic domains still 
adsorbed to the oil/water interface, impacting emulsion stability as a result of disrupting 
the interfacial layer (David Julian McClements, 2015; Singh & Sarkar, 2011), increasing 
the attractive hydrophobic forces between droplets and therefore the propensity for 
flocculation or coalescence (Golding, 2013). 
In the human GI tract, the polymeric protein layer at the oil/water interface in protein-
stabilised emulsions will encounter hydrolysis by proteases, losing the steric hindrance 
(repulsion) that usually prevents aggregation. The main whey protein in human breast 
milk is α-lactalbumin, whereas β-lactoglobulin, which exists in bovine milk, is not present 
in human breast milk (Heine et al., 1991). The specific structural differences in proteins 
determine their susceptibility to pepsin. Several studies have shown that β-lactoglobulin 
and α-lactalbumin were resistant or partially resistant to pepsinolysis at different pH 
levels (1.5-4.0), as structurally casein is more susceptible to pepsin proteolysis than β-
lactoglobulin (Astwood, Leach, & Fuchs, 1996; Chatterton et al., 2004; Dupont et al., 
2010; Inglingstad et al., 2010; Sakai et al., 2000; Thao et al., 2015). Emulsification can 
also alter the conformation of milk proteins upon adsorption on the oil/water interface, as 
indicated by Macierzanka and co-researchers (2009). These authors showed that β-casein 
and β-lactoglobulin, adsorbed on interfaces were more susceptible to pepsin than in the 
aqueous phase being consistent with two more recent studies (Maldonado-Valderrama, 
Wilde, Mulholland, & Morris, 2012; Sarkar, Goh, & Singh, 2010). However, for α-
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lactalbumin, the adsorbed protein showed more resistance to proteolysis at the interface 
than in the aqueous phase (Malaki Nik, Wright, & Corredig, 2010). 
Processing methods, such as heating or applying high hydrostatic pressure, can unfold 
proteins and increase the susceptibility of the proteins to pepsinolysis. This phenomenon 
is especially important in the case of β-lactoglobulin, where heating can partially unfold 
the protein structure and expose more cleavage sites for pepsin to hydrolyse (Reddy, Kella, 
& Kinsella, 1988; Sakai, Ogawa, Takashima, Mizunuma, & Manabe, 1997; Sitohy, 
Chobert, Dalgalarrondo, & Haertlé, 2001). 
Proteolysis, apart from reducing the thickness and mechanical strength of protein films at 
the oil/water interface(Golding, 2013), can also cleave the charged groups from the 
adsorbed interfacial proteins, reducing the electrostatic repulsion which may induce 
emulsion flocculation. Partial hydrolysis by pepsin on pre-formed β-lactoglobulin 
adsorbed at air/water interface did not impair the protein network (Gunning & Morris, 
2018) whereas, at a pure oil/water interface, pepsin hydrolysis could weaken the protein 
network, reducing its coverage and the interfacial elasticity (Maldonado-Valderrama, 
Holgado Terriza, Torcello-Gomez, & Cabrerizo-Vilchez, 2013; Scheuble, Geue, 
Windhab, & Fischer, 2014). This process can increase the propensity of film rupture and 
induce droplet coalescence. However, for β-casein, pepsinolysis has been shown to 
increase the elasticity of the protein network resulting in a more cohesive network at a 
pure oil/water interface (Maldonado-Valderrama et al., 2013). In this case, pepsin 
hydrolysis of the protein network increased the resistance of the β-casein emulsion to 
coalescence. 
For raw bovine milk and human milk, proteins exist in the serum phase (caseins and whey 
proteins) and as part of the membrane in the milk fat globules. The main proteins in the 
milk fat globule membrane, such as MUC 1, PAS III and butyrophilin, are largely 
glycosylated (Martini, Salari, & Altomonte, 2016; Singh, 2006). Studies have found that 
some of the membrane glycoproteins are less susceptible to pepsinolysis under gastric 
conditions compared to serum proteins in bovine milk (Hamosh et al., 1999; Le et al., 
2012). However, in a study by Ye et al. (2011) using washed cream (without aqueous 
proteins), peptides became dominant in the digestate after simulated gastric digestion (in 
the absence of gastric lipase) which indicated that most of the membrane proteins had 
been hydrolysed. By using high concentrations of pepsin, it was found that the membrane 
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proteins disappeared gradually on SDS-page gels, and peptides dominated on the bands. 
Since the study by Ye et al. (2011) did not provide enough information for the conditions 
of experiments, it is difficult to compare with the results obtained by Le et al. (2012) who 
found that glycoproteins were quite resistant to pepsinolysis. However, in the study by 
Ye et al. (2011), a variety of enzyme concentrations showed that at a higher enzyme level, 
the degradation of proteins in the milk fat globule membrane was substantial. In general, 
and as mentioned above, caseins in the milk serum are more susceptible to pepsin 
hydrolysis than β-lactoglobulin in whey protein. 
Some in vitro studies have observed aggregation or flocculation for both human and 
bovine milk in simulated gastric models for protein digestion (with or without the 
presence of gastric lipase) (Bourlieu et al., 2015; de Oliveira, Bourlieu, et al., 2016; de 
Oliveira, Deglaire, et al., 2016; Gallier et al., 2012; Ye et al., 2011). An in vivo study in 
rats showed an increased size in raw bovine milk fat globules during gastric digestion 
(Gallier et al., 2013). In this study, gastric lipase was present (and hence lipolysis was 
presumably occurring), whereas the previous in vitro studies cited, were carried out in the 
absence of lipase (to study protease activity) with the milk fat globules remained intact 
during digestion with no coalescence being observed (Bourlieu et al., 2015; de Oliveira, 
Bourlieu, et al., 2016; de Oliveira, Deglaire, et al., 2016; Gallier et al., 2012; Lueamsaisuk, 
2015; Ye et al., 2011). Therefore, the network formed by serum proteins and their 
hydrolysates could be the reason for the aggregation observed. 
During simulated gastric digestion (in the absence of gastric lipase), the ζ-potential of the 
milk fat globule did not change significantly, suggesting that pepsinolysis had not 
changed much the charge of the membrane (Gallier et al., 2012; Ye et al., 2011). The 
electrostatic repulsion provided by charges of proteins and peptides at the interface and 
the steric repulsion from intact undigested glycoproteins may provide protection and 
barrier from the coalescence of the fat globules (Gallier et al., 2012; Le et al., 2012). 
2.5.3 Lipolysis 
When dealing with gastric digestion, lipolysis is not usually discussed in isolation but 
combined with proteolysis by pepsin. Gastric lipolysis may change the stability of the 
emulsion as well as its specific surface area. During gastric lipolysis, the generation of 
free fatty acids and other lipolysis products accumulate on the oil/water interface and 
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change the interfacial tension and film properties. The interface becomes more 
hydrophobic compared to the initial state where proteins occupied the interface. 
Instability may occur when lipolysis products create more attractive forces between the 
droplets. Golding et al. (2011) have found that a whey protein-stabilised emulsion 
showed a steady increase in average particle size and flocculation, under a confocal 
microscope. The rate of gastric lipolysis was significantly affected by the changes in the 
droplet surface area in both in vitro and in vivo studies. Moreover, proteins were proven 
not to act as a barrier for gastric lipolysis as shown by a study using pure oil/water 
interface covered by β-lactoglobulin and β-casein (Maldonado-Valderrama et al., 2013), 
where the authors found that lipolysis still occurred. 
A study by Luo et al. (2019) has investigated the oil droplets coated by either the lipids 
from the milk fat globule membrane or by casein in a simulated in vitro infant gastric 
system. It was found that the droplets covered by the lipids from the milk fat globule 
membrane were generally more stable during digestion than the casein-coated ones. The 
absolute ζ-potential of casein-coated droplets dropped during gastric digestion showing 
instability, due to a decrease in the electrostatic repulsion. They observed an increase in 
the droplet size and large aggregations formed at the end of the simulated gastric digestion. 
Because of the unique tri-layer membrane interface with integrated proteins in the 
membrane, the interfacial properties of the milk fat globule membrane are very different 
from other emulsions stabilised by surfactants or biopolymers. Gastric lipase has been 
proven to have an affinity for the membrane, and so it can adsorb on the mono 
phospholipid layer on the oil/water interface (Pafumi et al., 2002). Thus the milk fat 
globule membrane naturally provides favourable conditions for gastric lipase to adsorb 






Figure 2.10 A and B transmission electron microscope images of fat globules in the chyme 
collected from rats 180 min after gavaging raw bovine cream, scale bar = 2,000 nm (A) and 
10,000 nm (B), images adapted from Gallier et al. (2013). Reproduce with permission from 
Elsevier. C, a phase-contract image of milk fat globule in gastric chyme of a 10-day-old suckling 
rat, magnification: ×10,000, image adapted from Berendsen & Blanchette-Mackie (1979). 
Reproduce with permission from John Wiley and Sons. 
 
Figure 2.11 A Confocal laser scanning microscope image under DIC (differential interference 
contrast) mode of milk fat globules in the chyme collected from rats 180 min after gavaging 
raw bovine cream, scare bar = 25 µm, image adapted from Gallier et al. (2013). Reproduce 
with permission from Elsevier. B, Scanning electron image of artificial emulsion droplets 
hydrolysed by human gastric lipase, magnification: × 5,400, image adapted from Pafumi et al. 
(2002). Arrows indicate protrusions on the membrane surface. Reproduce with permission 
from American Soc for Biochemistry & Molecular Biology. 
As fat is majorly digested in the small intestine, studies on gastric lipolysis are very 
limited. As found for protein-stabilised globules, the gastric lipolysis of the MFGM 
stabilised globules strongly related to proteolysis in both in vitro and in vivo studies. 
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During gastric digestion, proteins aggregate due to pH and proteolysis in the stomach. 
Researchers have observed fat globules trapped in the aggregated network of proteins and 
peptides with membrane structure remaining intact in some in vitro studies (Bourlieu et 
al., 2015; de Oliveira, Bourlieu, et al., 2016; de Oliveira, Deglaire, et al., 2016). Another 
study also reported that the droplet size of fat globules from raw bovine milk increased 
in a simulated gastric system (Garcia et al., 2014). Similarly, an in vivo study (Gallier et 
al., 2013) in rats and an in vivo preterm infant study (Bourlieu et al., 2017) also found an 
increase in droplet size similar to an in vitro study (Garcia et al., 2014) when digesting 
milk fat globules in the gastric phase. The irregular surface of the fat globules with 
protrusions (Gallier et al., 2013) in Figure 2.11, and lamellar phase at the interface (Figure 
2.10) were observed after gastric digestion in rats, which was also observed in another in 
vivo study in suckling rats (Berendsen & Blanchette-Mackie, 1979). In an in vitro study 
using phospholipid-emulsified artificial emulsions by Pafumi et al. (2002), trapped 
gastric lipase was observed in the accumulated lipolytic products on the surface (Figure 
2.11). Thus, it is reasonable to presume that the protrusions in the rat study were 
accumulated lipolytic products from gastric lipolysis of triglycerides. 
Gastric lipolysis has been proven to be a fundamental step in the lipid digestion process, 
which provide a favourable interface for pancreatic lipase, co-lipase and bile salts in the 
intestinal phase for further hydrolysis of triglycerides in the lipid core (Gargouri, Pieroni, 
et al., 1986; Hamosh, 1979b; Hamosh, Bitman, Wood, Hamosh, & Mehta, 1985). 
2.5.4 Temperature and mechanical forces 
The body temperature can also influence the interfacial properties of protein-stabilised 
emulsions in the gastric phase. Scheuble et al. (2014) observed the weakening of the 
interfacial layer of β-lactoglobulin-emulsified medium-chain triglyceride oil when the 
temperature increased to body temperature in an acidic environment. In addition, the 
shearing forces in the stomach can also increase the collision rate of the oil droplets, 
thinning or impairing the interface of the oil droplet, which may further induce instability. 
2.5.5 Droplet size and the surface area of milk emulsions 
It can be argued that the emulsion structure of human breast milk has evolved to provide 
the most effective design for digestion of fat within the neonatal digestive tract. However, 
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the structural factors of infant formulae, such as droplet size, interfacial composition, 
changing interfacial properties and inhibition effect of additional compounds, may 
adversely influence gastric and small intestinal lipid digestion. 
When milk emulsions enter in the neonatal stomach—because of the low shear rate in the 
oral environment and very limited oral process—the size of the oil droplets is expected 
to remain unchanged to the initial size upon ingestion. However, gastric lipase, in acting 
to hydrolyse the triglyceride component of fat droplets, has a pronounced effect on the 
interfacial and emulsion size and structure.  
Research with some in vitro systems has demonstrated that the rate of lipolysis was 
inversely correlated to the droplet size. With the changing pH in the stomach, no 
correlation was found between emulsion droplet size and gastric pH. The fat droplets with 
smaller size are likely to induce more extensive gastric lipolysis as they have a larger 
surface area for lipase adsorption. A study which collected gastric juice from human 
adults and obtained rabbit gastric lipase and examined the gastric lipolysis of four 
different emulsions with droplet sizes of 0.19 m, 0.43 m, 0.46 m, and 3.18 m (Borel 
et al., 1994) has observed greater fatty acid generation for the fine emulsions compared 
to the coarse ones (Figure 2.12). to be used in the experiment. 
 
Figure 2.12 The release of free fatty acids by human gastric lipase as a function of incubation 
time. Different letters (a, b or c) indicated a significant difference (p<0.05) at given times (Borel 
et al., 1994). Reproduce with permission from Elsevier. 
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Another study has shown similar findings that emulsions with a lower surface area could 
be correlated with a lower rate of lipolysis (Keogh et al., 2011). Similar results have been 
found with pancreatic lipase in an in vitro study (Berton et al., 2012), where the rate of 
lipolysis by this lipase was found to be 4.6-fold higher in small native milk fat globules 
(1.8 m) than in large milk fat globules (6.7 m). However, it should be noted that the 
latter study conducted the experiments at 20 C a lower temperature than physiological 
temperature (37 C). 
Some in vivo studies with human trials have also confirmed that the rate of lipolysis by 
gastric or pancreatic lipase can be related to droplet size (notably under highly controlled 
conditions). Armand et al. (1999) used a fine emulsion (0.7 m) and a coarse emulsion 
(10.1 m) for digestion and absorption tests performed in healthy human subjects. They 
found that during four hours of digestion in the human GI tract, the coarse emulsion 
resulted in no much change to droplet size. However, the fine emulsion had a four- to 
nine-fold of increase in median diameter of the emulsion droplets. Gastric lipolysis rate 
was found to be 1.7 to 3.3 times higher in the fine emulsion than in the coarse emulsion 
(Figure 2.13). 
 
Figure 2.13 The percentage of four hours of gastric lipolysis of fine and coarse emulsions 
(Armand et al., 1999). Reproduce with permission from Oxford University Press. 
Concerning the digestibility of human and formula milk, a study in premature infants 
showed that gastric hydrolysis of human milk is 1.7 to 2.5-fold greater than that of infant 
formula after ingestion (Armand, Hamosh, et al., 1996) although the diameter of human 
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milk fat globules (4 m) was much larger than that of the infant formula (0.6 m). Again, 
the composition of the fat differs between human breast milk and infant formula probably 
influencing the digestion. Hence, chemical differences at the oil/water interfaces of the 
two milk types could concurrently influence the affinity of lipase. The unique 
phospholipid tri-layer stabilising human milk fat (Lopez & Menard, 2011) which differs 
markedly from that of milk-protein-stabilised infant formulae is considered to facilitate 
the binding of lipase (Bourlieu-Lacanal et al., 2015; Jensen et al., 1992). Although it is 
difficult to compare studies conducted in vitro and in vivo with adult human subjects as 
the emulsion may be affected by oral processing (D. J. McClements et al., 2009), this 
may have an insignificant impact on infants as they swallow milk with a minimal oral 
process. 
A considerable amount of studies has investigated gastric lipid digestion from both in 
vitro and in vivo approaches. However, the relationship between structural changes in the 
emulsions and the degree of gastric lipolysis is still not clear, especially in the neonates. 
The in vitro approaches have been used over the past two decades, allowing increasingly 
sophisticated models of digestion to be built. However, the gastric phase of lipid digestion, 
which is especially crucial for neonates, has been largely neglected because of its minor 
contribution to adult digestion. This project aimed to understand the relations between 
the structural changes in lipid digestion and the degree of lipolysis in a neonatal gastric 
model. In this project, we used an in vitro model with a low shear rate that could 
physiologically represent the low shearing forces in neonatal gastric phase. In this way, 
we were able to investigate the effects of different reactants and substrates on gastric 
lipolysis in a separate or combined manner. 
2.6 Development of in vitro gastric digestion and analysis of 
FFA  
In vitro models are widely used to mimic digestion in the GI tract. Different types of 
models have been introduced in the previous sections (Chapter 2.4.4). Researchers have 
adjusted various parameters used in the in vitro models through the years, to answer 
specific research questions. For lipid digestion, the simulation of the processes in the 
mouth, stomach and small intestine are usually studied separately. 
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2.6.1 Determination of the degree and rate of lipolysis 
Quantification of lipid digestion has been investigated for decades. Titration is the most 
commonly used method. As it is an assay for determining lipase activity, an auto-titration 
method ⸺ the pH-stat method has been introduced to analyse the rate of lipolysis in lipid 
digestion conducted in the in vitro studies. The pH-stat method determines the amount of 
free fatty acids released by continuous titration with a base to a constant pH level. It is 
usually used under small intestinal conditions (pH 6.8-8.0) (Helbig et al., 2012) which is 
quite limited. The pKa of many fatty acid esters from dietary fats is at 4.7-4.9 (de Maria, 
Fernandez-Alvaro, ten Kate, & Bargeman, 2009; D. J. McClements & Li, 2010). Thus, 
this method is not suitable for measuring the rate of lipolysis under gastric conditions 
where the pH would be 2-6. Besides, apart from the fatty acids released from simulated 
digestive lipolysis, diglycerols and monoglycerols are also generated from the process. 
This method only gives a rough estimation of the released fatty acid from lipolysis, and 
therefore cannot accurately quantify all of the lipolytic products. Other than the pH-stat 
method, more accurate methods such as GC, TLC and mass spectrometry have been used 
in many in vitro and in vivo studies (Bourlieu et al., 2015; Brenna, 2013; Helbig et al., 
2012; Zhu, Ye, Verrier, & Singh, 2013). For instance, the reversed-phase high-
performance liquid chromatography (HPLC) was used to analyse the released fatty acids 
from lipolysis of triglycerides with the advantage of quick sample preparation. However, 
due to limitation of the detectors, this method is more suitable for a pure substrate—such 
as defined triolein, rather than a mixture of substrates (Ergan & André, 1989; Thomson, 
Delaquis, & Mazza, 1999; Veeraragavan, 1990). Compared to HPLC, GC with a flame 
ionisation detector (FID) have shown to perform better in determining the released fatty 
acids by analysing the fatty acid methyl esters (FAMEs) (Gallier et al., 2012; Helbig et 
al., 2012; Zhu et al., 2013). However, it is difficult to differentiate other lipolytic products 
such as diglycerides and monoglycerides. Some researchers have combined TLC with 
flame ionisation detector that could be able to analyse and quantify all of the lipolytic 
products (free fatty acids, mono- and diglycerides and residual triglycerides) more 




2.6.2 Determination of the changes in the structural properties of 
emulsions during gastric digestion 
Changes in structural and interfacial properties of emulsions can be quantified by 
measuring the emulsion droplet size (particle size, via light scattering or microscopy) and 
the droplet surface charge (-potential analysis). Microscopy techniques such as confocal 
microscopy, cryo-transmission electron microscopy, scanning electron microscopy and 
transmission electron microscopy have been widely used to observe the morphological 
changes of the oil droplets during digestion (Gallier, 2010; Gallier et al., 2013; Singh & 
Gallier, 2017). These tools can not only observe the transitions during the digestion 
process but also provide insights into the mechanism of lipid digestion and absorption. In 
some of the most recent studies, scattering techniques such as small-angle X-ray 
scattering (SAXS) have been introduced in the research of lipid digestion to observe lipid 
assemblies during emulsion digestion (Marze, Gaillard, & Roblin, 2015; Salentinig, Phan, 
Hawley, & Boyd, 2015). 
2.7 Summary 
In conclusion, lipid digestion is vital for infants, and the structural properties of infant 
milk can play an essential role in the digestive process. Understanding of the GI tract 
environment in infants can help us building physiologically valid in vitro models to study 
lipid digestion in the neonates. Nowadays, research is increasingly focusing on structural 
properties and their relationship to lipid digestion in adult human subjects from both in 
vitro and in vivo perspectives. However, limited attention has been placed on 
understanding the relationship between the structural changes and the degree of lipid 
digestion in infants, and how digestive variables in the GI tract could influence the 
process. Many findings are built on the experimental data using different in vitro systems 
to simulate neonatal GI environment. However, it is still difficult to compare those studies 
with each other. Therefore, this project aimed to focus on understanding the relationship 
between structural changes and the extent of lipolysis in a neonatal gastric model, and the 




Chapter 3 Materials and methods 
3.1 Materials 
Bovine blood haemoglobin H2500 was purchased from Sigma-Aldrich Pty Ltd., St. 
Louis, MO, USA. 
Bovine lactoferrin powder was provided by the Fonterra Research and Development 
Centre, Palmerston North, New Zealand (made in December 2015). This powder 
contained 93.98% of lactoferrin, with 0.65% of ash, 1.09% of moisture and 0.014 % of 
iron content (14 mg Fe/100g powder, 10.9% of iron saturation). 
Fungal lipase derived from a selected strain of Rhizopus oryzae was chosen as an 
alternative for human gastric lipase. Fungal lipase 8000 is purchased from Connell 
Brothers Company Australia Pty Ltd., Australia. This fungal lipase was derived from a 
selected strain of Rhizopus oryzae (ATCC 1996) with an activity of 80 LU/mg. It was a 
food-grade lipase and was classified as triacylglycerol acylhydrolase (EC 3.1.1.3). Fungal 
lipase 8000 primarily hydrolysed triglycerides at sn-1 and sn-3 positions, producing short, 
medium and long-chain fatty acids, di- and mono-glycerides. It was active and stable over 
a wide pH range from 4.5 to 8.5 and with optimal performance at pH 7. This fungal lipase 
was active at a temperature up to 45 ºC with an optimal temperature at 35 to 40 ºC. 
Intralipid® was a commercial soya bean oil in water emulsion stabilised by 
phospholipids from egg lecithin intended for intravenous use (purchased from Fresenius 
Kabi Australia Pty Limited, NSW Australia). This product contained 20% of soybean oil, 
0.12% egg lecithin and 0.22% glycerol. The main phospholipid components in egg 
lecithin are phosphatidylcholine (PC, 80.5%) and phosphatidylethanolamine (PE, 11.7%). 
Minor components also include lysophosphatidylcholine (LPC), sphingomyelin (SM), 
and neutral lipids (Palacios & Wang, 2005). The pH has been adjusted to 6.0-9.0 by 
hydrochloric acid (HCl). The osmolality was 350 mosmol/L. Oil in the diluted Intralipid 
emulsion was stabilised by egg lecithin containing phosphatidylcholine (PC), 
phosphatidylethanolamine (PE) and sphingomyelin (SM). The head groups of these 
phospholipids show no charge at pH 3.5. Thus, the negative surface charge is reflected in 
the phosphate group. 
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Myristic acid was purchased from BDH Ltd, Poole, England. 
S-26® Gold Newborn [Wyeth Nutrition (Singapore) Pte. Limited, Singapore] was 
purchased from a local supermarket in August 2018. 
Palmitic acid and Pentadecanoic acid (~ 99% capillary GC) were purchased from 
Sigma-Aldrich Pty Ltd., St. Louis, MO, USA. 
Porcine gastric pepsin P7000 (EC 3.4.23.1) powder with an activity ≥ 250 units/mg 
solid was purchased from Sigma-Aldrich Pty Ltd., St. Louis, MO, USA. 
Deionised water (Milli-Q water) was purchased from Millipore, Bedford, MA, USA. 
All other chemicals were purchased from Sigma-Aldrich Pty Ltd., St. Louis, MO, USA. 
3.2 Methods 
3.2.1 In vitro model for neonatal gastric digestion 
The set-up for the in vitro neonatal gastric digestion based on the work by Lueamsaisuk 
et al. (2014). In this in vitro set-up, a 400 mL glass beaker with a 7.5 cm diameter was 
placed in a water bath at 37 C. Mixing within the stomach was simulated by a magnetic 
stirring bar with a diameter of 7.0 cm rotating at 10 rpm using a submersible device. The 
shear rate at this speed was calculated to be 16.25 s-1. It should be noted that the value is 
still higher than 0.7 s-1 which has been calculated as the maximum shear rate occurring in 
the human stomach (Lentle & Janssen, 2011; Lentle et al., 2010). In fact, due to the 
immature development of stomach for neonates, the actual shear rate in the neonatal 
stomach should be even lower than that of the adult. However, most of the stirring devices 
used in in vitro studies cannot achieve such a low shear rate. Therefore, the lowest rotating 
speed in the current device was chosen, as the stirring rate throughout this entire study 
(10 rpm).  
Simulated gastric fluid (SGF) was prepared by dissolving 200 mg of sodium chloride 
(NaCl) in Milli-Q water. The pH of the solution was adjusted to 2, 3.5, 4.5 or 5.5 with 0.1 
M HCl solution, and the total volume made up to 100 mL with Milli-Q water. This pH 
range was aiming at simulating the postprandial variation of pH in infants’ stomach, as 
reported in Lueamsaisuk et al. (Lueamsaisuk, 2015; Lueamsaisuk et al., 2014). An 
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amount of 450 mg of dry powdered porcine pepsin (800 - 2500 units/mg protein) and 20 
mg of dry powdered Rhizopus oryzea lipase (80 U/mg) was first hydrated with a small 
amount of Milli-Q water (usually 5 to 10 times of the enzymes own weight) and added to 
the SGF (details in the following section). 
A schematic of this process is shown in Figure 3.1. 
 
Figure 3.1 A scheme of in vitro digestion set-up. 
3.2.2 Pepsin assay 
The pepsin assay method was modified from Minekus et al. (2014). Pepsin powder was 
brought to room temperature and 100 mg of pepsin were weighed accurately into a tube. 
A pepsin stock solution 10 mg/mL was made by adding a 0.15 M NaCl solution (prepared 
with Milli-Q water), and the pH was adjusted to 6.5 with 0.1 M NaOH. An aliquot of 50 
µL pepsin stock solution was diluted (1:20) by adding 950 µL of Milli-Q water and stored 
on ice. A haemoglobin stock solution was made by adding 0.5 g bovine blood 
haemoglobin to 20 mL Milli-Q water followed by 5 mL 0.3 M HCl in order to achieve 
pH 2. 
In order to generate the reaction curve, an amount of 12×2 mL Eppendorf tubes with 500 
µL haemoglobin stock solution in each tube were prepared. A 100 µL of diluted pepsin 
was added to each six of them and were incubated in a shaking water bath set at 37 °C 
for 0, 2, 4, 6, 8, 10 min. An amount of 1 mL of 5% w/v TCA (tricyclic antidepressant) 
was added in each tube to stop the reaction. The other six tubes were marked as blank 
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tubes where 1 mL of 5% w/v TCA was added in each tube in advanced before incubation. 
The same amount of diluted pepsin (100 µL) was added to each of the six blank tubes and 
was also incubated in the shaking water bath for 0, 2, 4, 6, 8, 10 min. After incubation, 
the 12 tubes were centrifuged at 12,000 × g for 6 min and warmed up to room temperature. 
The supernatant was diluted (1:4), by adding 250 µL supernatant to 750 µL Milli-Q water. 
As a result of this reaction, haemoglobin was hydrolysed by pepsin into TCA-soluble 
peptides with absorbance at A280. The absorbance of water at 280 nm was used as 
background reading, and the absorbance of each sample was read at this wavelength in 
quartz cuvettes. Results were reported in units defined as below (one unit of pepsin will 
produce ∆A280 of 0.001 per minute at pH 2.0 at 37 ˚C measured as TCA-soluble products 
using haemoglobin as the substrate). The unit was calculated as: 
















∆A280 test/∆t = ktest is the slope of the test curve (linear line) 
∆A280 blank/∆t = kblank is the slope of the blank curve (linear line) 
Xpepsin is the concentration of pepsin powder in the final reaction mixture (quartz cuvette) 
[mg/mL] 
3.2.3 Lipase assay 
The assay method carried out on the fungal lipase used here was modified from Minekus 
et al. (2014) and was conducted by pH-stat titration using Intralipid (phospholipid-
emulsified soybean oil) as the substrate. The free fatty acids released from lipolysis were 
titrated at a constant pH of 7.0 with 0.05 M NaOH for 20 min. The rate of lipolysis was 
calculated based on the first 5 min of titration. Results were reported in units defined as 
1 U = 1 μmol carboxyl group (i.e.,-COOH) released per minute at 37 ºC and pH 7.0.  
The Intralipid substrate solution was prepared as described above in the simulated 
digestion section with the only difference being that a higher enzyme concentration was 
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used (16 times greater). The pH of the digestate was adjusted to 7.0 at the starting point 














kFFA is the amount of fatty acids released per minute (in moles), 
VNaOH/t is the initial rate of lipolysis (mL/min) 
1 mole/min are the units of U fungal lipase. 
3.2.4 Analysis of lipolysis products by gas chromatography (GC) 
3.2.4.1 Validation of the GC instrument 
Validation of the GC instrument was done using six equivalent GC vials with 1 mL 
mixture of solvents and 30 µL internal standard (IS) Pentadecanoic acid (C15:0) stock 
solution (20 g/L) with or without the initial digestate extractions in the absence of 
enzymes. The coefficient of variation of this validation test is shown in Table 3.1 and 
indicating the reproducibility of the GC instrument. 
Table 3.1 The standard deviation and coefficient of variation of the area under the curve 
(mV*min) using an internal standard. 
IS C15:0 Multiple injections Multiple vials 
Standard deviation 2.71 5.17 
Coefficient of variation (%) 4.86 10.35 
IS C15:0 with digestate Multiple injections Multiple vials 
Standard deviation 6.50 5.24 











Table 3.2 Parameters of the linear regression of the calibration curve. 
 C14:0 C16:0 
b 1077.550 981.696 
SEM (b) 39.286 32.918 
df 1;5 1;5 
F 752.321 889.368 
Sig. <0.001 <0.001 
R2 0.993 0.994 
b, slope value. 
SEM (b), standard error of the mean of b. 
df, degrees of freedom and residual degrees of freedom. 
F, F value. 
Sig., p-value, α=0.05. 
R2, coefficient of determination. 
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3.2.4.2 GC analysis 
The samples were analysed in a ThermoQuest Trace GC 2000 (Thermo Fisher Scientific, 
Milan, Italy). An amount of 0.6 µL of the sample was injected into a guard column (Fused 
silica capillary tubing, deactivated, 0.50 m × 0.53 mm ID, Alltech Associates Inc., 
Deerfield, IL) by an autosampler Thermo Scientific AS 2000 (Thermo Fisher Scientific, 
Milan, Italy). The sample passed through a guard column and then into an Agilent 
capillary non-polar column [DB-5ht, 8 m (length) × 0.32 mm (ID), 0.10 µm (film), -60 - 
400 °C (the temperature limit), Santa Clara, California, United States]. The carrier gas 
was helium, and it was running at a constant flow rate of 2 mL/min. Temperature ramped 
from 60 °C (for 1 min) to 380 °C (for 8 min) at a heating rate of 10 °C/min. The total run 
time for one sample was 41 min.  Signals were detected by an FID detector. Calibration 
curves were produced using a series of known concentrations of mixed fatty acids 
solutions (similar amount of myristic acid and palmitic acid in hexane) as in Figure 3.2. 
The parameters of the calibration curves showed that the area under the peak (AUP) was 
proportional to the sample concentration. 
The identification of peaks was performed by comparing the retention time of myristic 
and palmitic acids used to produce the calibration curve, to those from the analysed 
samples. Their retention time and area under the peak were recorded and integrated by 
using Chromeleon™ 7.2 Chromatography Data System Software (Thermo Fisher 
Scientific, Milan, Italy). 
3.2.5 Scanning electron microscopy (SEM) 
The digesta samples (1 mL) were first mixed with 3% agarose at a ratio of 1:1 (v/v) and 
then cut into cubes (approximately 10×5×5 mm). The cubes were placed in a primary 
fixative, which consisted of 3% glutaraldehyde and 0.1M sodium cacodylate buffer at pH 
7.2 for at least 8 hours at room temperature. Then the cubes were washed three times, 10- 
15 min each with 0.1 M pH 7.2 sodium cacodylate buffer. Then the cubes were dipped 
into 1% osmium tetroxide sodium cacodylate buffer for an hour at room temperature and 
washed again with 0.1 M pH 7.2 sodium cacodylate buffer three times. Each sample cubes 
were dehydrated in graded ethanol series with a volume percentage of 25%, 50%, 75%, 
95% and 100% for 10-15 min and washed in 100% ethanol for an hour. 
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The sample cubes were critical point dried using liquid CO2 and 100% ethanol was used 
as the intermediary by Polaron E3000 series II critical point drying apparatus (Quorum 
Technologies Ltd, Laughton, United Kingdom). The sample cubes were then torn to 
expose the oil droplets needed to be observed. They were mounted on to aluminium stubs, 
sputter-coated with approximately 100nm of gold (Bal-Tec SCD 050 sputter coater) and 
viewed in the FEI Quanta 200 Environmental Scanning Electron Microscope at an 
accelerating voltage of 25 kV. This method was a standardised method for analysing 
milk-like samples for SEM analysis in Manawatu Microscopy & Imaging Centre, 
Palmerston North, New Zealand. 
3.2.6 Transmission electron microscopy (TEM) 
A 1.5 mL of digestate was sampled at time 0 min and after 120 min. The liquid sample 
was injected into 3% agarose tubes and sealed with agarose to form an enclosed capsule. 
The tubes were placed into 3% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 
7.2) for at least 24 hours. The buffer was then washed in 0.1 M sodium cacodylate (pH 
7.2) three times for 45 min per wash. The samples were post-fixed in 1% osmium 
tetroxide in 0.1 M sodium cacodylate buffer for an hour at room temperature and 
overnight at 4 C and finally brought up to room temperature for an hour. The buffer was 
rewashed three times in 0.1 M sodium cacodylate as described above. The samples were 
then dehydrated through a graded acetone series (25%, 50%, 75%, 95%, 100%, 100%, 
and 100%) for 45 min for each grade. The samples were then put into resin: acetone 
(50:50) and placed on a stirrer overnight then replaced by fresh 100% resin and placed 
on the stirrer for another 8 hours. This step was repeated four more times. Then the 
samples were embedded in moulds with fresh resin and cured at 60 C oven for 48 hours. 
Light microscope sections were cut at 1 m using a glass knife on the ultramicrotome 
(Leica EM UC7, Germany) and heat-fixed onto glass slides. These sections were stained 
with 0.05% toluidine blue for approximately 12 seconds and viewed under the light 
microscope. Those blocks were then trimmed down to the selected areas and cut using a 
diamond knife (Diatome, Switzerland) at 100 nm and then stretched with chloroform and 
mounted on a grid using a Quick Coat G pen (Daido Sangyo, Japan). The grids were 
stained in saturated uranyl acetate in 50% ethanol for 6.5 min and washed with 50% 
ethanol, and Milli-Q water then stained in lead citrate (Venable & Coggeshall, 1965) for 
another 6.5 min and followed by a wash in Milli-Q water. Then the samples were viewed 
54 
 
and imaged with a transmitted electron microscope FEI Tecnai G2 Spirit BioTWIN (FEI 
Company, Czech Republic) with a camera Veleta (Olympus SIS, Germany). Samples 
were analysed in duplicate. This method was a standardised method for analysing milk-
like samples for TEM analysis in Manawatu Microscopy & Imaging Centre, Palmerston 
North, New Zealand. 
3.2.7 Statistical analysis 
Every experiment was triplicated. The results from GC were analysed using IBM SPSS 
Statistics 25.0 (IBM, Armonk, New York, United States) and SigmaPlot 14.0 (Systat 




Chapter 4 Using 1H NMR for lipolysis analysis 
4.1 Introduction 
Monitoring the process of lipolysis is of great importance in studying the dynamics of 
lipid digestion. Studies in the past few decades have used a variety of different methods 
to quantify lipolytic products from lipid digestion. As discussed in the literature review, 
chromatographic methods, such as HPLC and GC, and titration methods such as the pH-
stat method are widely used for direct or indirect quantification of free fatty acids 
generated from lipolysis. However, the disadvantages of those methods are also evident. 
For GC method, the standard FAME analysis requires chemical modification of lipolytic 
products and is always time-consuming (Brenna, 2013; Helbig et al., 2012; Rueda et al., 
2014; Zhu et al., 2013). For the pH-stat method, this tends to be more suitable for 
digestion under neutral pH, and is, therefore, more widely used in studying lipid digestion 
in the small intestine rather than in the gastric phase (Helbig et al., 2012). Additionally, 
the titration method may not give reliable results when conducting digestion in a complex 
simulated digestive system rather than simple ones (Hur et al., 2009), particularly due to 
buffering effects from compositions containing appreciable amounts of protein. Some 
more recent studies have shown that 1H NMR (Proton Nuclear Magnetic Resonance) 
spectroscopy may be a promising new method for analysing lipolysis in the complex lipid 
matrix or the lipid digestate (Nieva-Echevarría, Goicoechea, Manzanos, & Guillén, 2014; 
Nieva-Echevarría, Goicoechea, Manzanos, & Guillén, 2015). The 1H NMR method was 
reported to be less time consuming and did not require chemical alteration of the lipolytic 
products generated from lipid digestion. However, it still required sampling at specific 
time points and lipid extraction before conducting 1H NMR analysis. 
In order to find a methodology to quantify the generation of free fatty acids during gastric 
lipolysis either in-situ or dynamically, and without terminating the reaction, we explored 
the possibility of adapting 1H NMR spectroscopy to monitor the dynamics of lipid 
digestion in a simulated gastric environment. This chapter provides an overview of 
methodology development using this approach and some initial findings, along with a 




4.2 Materials and Methods 
4.2.1 1H NMR spectroscopy 
1H NMR (Nuclear magnetic resonance) is an analytical chemistry technique used to 
determine the content and molecular structure of a sample. 1H NMR spectroscopy 
operates through the application of a magnetic field to nuclei and then measuring the 
amount of energy required to put various nuclei in resonance. Nuclei in different 
electronic environments require different amounts of energy to bring them into resonance. 
A typical 1H NMR spectrum provides a peak representing the energy required to bring 
each nucleus into resonance. The technique can also provide information for the dynamics, 
reaction state, and chemical environment of the molecules. 
In the 1H NMR spectra, molecules usually present themselves in a well-resolved and often 
predictable way. In the simulated gastric lipolysis process of our study, one molecule of 
triglycerides is hydrolysed by fungal lipase, liberating two free fatty acids and one 
monoglyceride. The release of fatty acid creates a unique proton environment around its 
carboxyl group, which produce a unique magnetic field. This magnetic field makes the 
proton generated from the reaction resonance in a unique frequency. Since the resonance 
frequency is depended on the applied magnetic field in the 1H NMR, this will generate a 
unique peak on the spectra, which represents the released free fatty acids from the reaction. 
The peak will show at a specific position on the spectrum as δ  ̶  ppm (parts per million). 
The δ unit is defined as 𝛿 =
𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑑𝑜𝑤𝑛𝑓𝑖𝑒𝑙𝑑 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑠𝑖𝑔𝑛𝑎𝑙 (𝐻𝑧)
𝑂𝑝𝑒𝑟𝑎𝑡𝑖𝑛𝑔 𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑁𝑀𝑅 (𝑀𝐻𝑧)
. Since δ is a 
ratio not unit, it is independent of the applied magnetic field of NMR. 
A 500 MHz 1H NMR (Bruker BioSpin GmbH, Karlsruhe, Germany) was used for all 
experiments. A 1-dimensional proton spectrum was acquired. The water signal was 
suppressed using a standard pulse sequence from pulsed-field gradient (Zgesgp, Bruker, 
Germany). The free induction decay was acquired with 16 k data points for 1.5 seconds 
with a recycle delay of 2 seconds. Spectra were processed using Mnova MestreNova 
NMR processing software (MestreNova, Spain). 
A D2O matched symmetrical microtube (Shigemi 5 mm Symmetrical NMR microtube 
assembly matched with D2O, bottom length 8 mm, Merck KGaA, Darmstadt, Germany) 




Figure 4.1 Shigemi 5 mm Symmetrical NMR microtube assembly matched with D2O, bottom 
length 8 mm (Merck KGaA, 2020). 
A sample of initial digestate was prepared by mixing a diluted Intralipid emulsion 
containing 3.6% w/v fat, and SGF at a ratio of 20:50 v/v. In this experiment, the volumes 
of the diluted Intralipid and SGF were 40 ml and 100 ml, respectively. An amount of 20 
mg of dry powdered Rhizopus oryzea lipase (80 U/mg) was first hydrated with a small 
amount of Milli-Q water (usually 5 to 10 times of the enzymes own weight) and then 
added to the initial digestate. The 1H NMR analysis of each sample was done by filling 
the sample up to 17 mm in the D2O matched symmetrical microtube from the bottom. 
The microtube was rotated at 10 rpm during lipolysis in 1H NMR. A spectrum was 
acquired every 5- minute intervals during the length of reaction. Two lipolysis tests of the 
digestate were conducted at pH 3.5, 37 C for 85 min. 
4.2.1 Tests of adding fatty acid as an internal standard 
Oleic acid was added as an internal standard in the initial digestate without any addition 
of digestive enzymes to test the feasibility of adding fatty acid as an internal standard. 
Addition of oleic acid in the Intralipid emulsion (3.6% w/v) digestate and an artificial 
emulsion made by 3.6% w/v soybean oil and 1% Tween 20 w/v was tested respectively 
at neutral pH, 37 ºC. The final concentration of oleic acid in the digestate was 10 mM. 
The artificial emulsion was blended by an ULTRA-TURRAX T 25 digital dispenser  
(IKA, Germany) at 6000 rpm for 3 min. 
58 
 
4.2.2 Calculation of FFA concentration 
In order to calculate the concentration of liberated fatty acids from lipolysis, 3-
(trimethylsilyl) Propane Sulfonic Acid Sodium Salt (DSS, ) was used 
as an external reference. 
A known amount of DSS was added into the initial digestate without lipase existing as a 
reference digestate, concentration of the DSS in the reference digestate was calculated 
accordingly. The reference digestate was filled in the microtube and analysed by 1H NMR. 
Since this DSS was referred to as external reference without adding lipase, this reference 
digestate was different from test digestate for lipolysis. 
Since in one molecule of DSS, there are three methyl groups around the silicon atom 
where the 9 protons (hydrion) in the methyl groups are in the same electronic environment 
(chemical environment), whereas in one molecule of fatty acid there is only one proton 
in the carboxyl group which presents a unique chemical environment. Therefore the two 
different proton environments show two separate peaks on the spectrum. Since the ratio 
of area under the two peaks and the ratio of the proton number of the two peaks for which 
responsible are the same, to get the same area under the peak, the number of fatty acid 
molecules needs to be nine times of the number of DSS molecules. It means in the same 
digestate, the concentration of free fatty acids should be nine times the concentration of 
DSS to achieve an equal area under the peak. Analysis of the signal intensity is done by 
calculating the area under the curve by integration. Then the initial concentration of free 














where Ct0 (FFA) is the initial concentration of FFA in the test sample at the starting time 
when the sample was placed into the 1H NMR, Cr (DSS) is the concentration of DSS in the 
reference digestate, It0 (FFA) is the integral (area under the peak) of free fatty acids at 
starting time when the sample was placed into the 1H NMR, and Ir (DSS) is the integral 
(area under the peak) of DSS in the reference solution. 
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Because DSS is used as an external reference which was different from the digestate 
samples during tests, the signal from DSS was integrated and cross-referenced to the test 
ones. When the concentration of free fatty acids is estimated from the reference, the 
changing of the concentration is proportional to that of the peak area. As lipolysis 
progresses, the concentration of the generated free fatty acids at different time points 
could be estimated accordingly. 
Data from 1H NMR was processed by MestReNova Version 9.1 (Mestrelab Research S.L., 
Spain). 
4.3 Results 
Before using the modified microtube with a flat bottom, as described in the methods, a 
conventional 1H NMR tube with a round bottom was initially tested. Since during 
digestion, the destabilised emulsion droplets creamed to the top of the digestate in the 
tube, the liquid/air interface, in this case, stayed out of the detection coil. This 
phenomenon can affect the quality of the spectra, leading to a signal loss of the free fatty 
acid, for that the density difference between liquid and air can influence the magnetic 
field. Then the D2O matched symmetrical microtube with flat bottom was used then to 
keep the creaming-up oil layer within the NMR coil to prevent the signal loss. 
In order to involve an internal standard fatty acid in the simulated dynamic digestion, 
oleic acid (10 mM) was used in the digestate at neutral pH, 37 ºC for testing. The addition 
in neither Intralipid nor artificial emulsion digestate showed a significant difference in 
the fatty acid peak on the spectrum at 3.18 ppm. Phase separation could be observed in 
the digestate before and after the tests. 
The 1H NMR analysis of samples was repeated twice and showed good repeatability. A 
unique proton peak of fatty acids appeared on the spectrum at 3.18 ppm when the initial 
pH of the digestate was 3.5 with the water signal being suppressed (Figure 4.2). A 
magnified view of the proton peaks of the liberated fatty acid during 85 min of digestion 
showed that the signal intensity (area under the peak) of free fatty acids increased along 
with time, indicating that the concentration of FFA liberated during lipolysis was 




Figure 4.2 A 1H NMR spectrum for Intralipid digested with lipase alone at pH 3.5 with a 
magnified view of free fatty acids liberated in 85 min. 
In both repeated 1H NMR tests, there was found to be a linear relationship between the 
concentration of total fatty acids in the digestate and reaction time (Figure 4.3). Linear 
regression applied to the data showed that the values of the slope were 1.337×10-5 and 
1.456×10-5 respectively, reflecting that the reaction rates of the two tests were close. The 
values of the coefficient of determination (R2) of the two regression lines were both close 
to 1, which showed excellent linearity of time to FFA concentration (Table 4.1). Tailing 
in the first 10 min was due to sample preparation in the flat tube. However, the intercept 
values of the two regression lines were different, although both tests were repeated at the 
same digestion conditions. This may due to two reasons, 1) there were already an amount 
of free fatty acids in the digestate originated from the diluted Intralipid before the 
initiation of digestion; 2) due to experimental operation, those two tests were not able to 
start simultaneously. Thus, the lipolytic reaction already commenced before the recording 




Figure 4.3 Two repeated lipolysis tests in 1H NMR using a D2O matched symmetrical microtube. 
The total fatty acid esters in triglycerides in the initial digestate (not including non-
hydrolysed fatty acids presented in the initial digestate) were estimated to be 33.6 to 34.2 
mM. After 85 min of digestion, the concentration of the total free fatty acids released 
from lipolysis in both tests was close to 0.1 mM. Thus, the extent of lipolysis was 
approximate to 0.3% for lipid digestion at pH 3.5 after 85 min. Clearly, the extent of 
lipolysis was quite low, which may suggest that the amount of triglyceride substrate may 
become far excess to that of fungal lipase. Therefore, repeated analysis is still needed in 
future statistical analysis. 
Table 4.1 Coefficients of the linear regression of two 1H NMR tests using a D2O matched 
symmetrical microtube. 
Test No. b SEM (b) a SEM (a) R2 
T1 1.377×10-5 5.343×10-7 2.338×10-2 1.557×10-3 0.978 
T2 1.456×10-5 2.603×10-7 30187×10-2 7.117×10-4 0.996 
a, intercept of the regression lines. 
SEM (a), standard error of the mean of a. 
b, the slope of regression lines, unit mM/s. 
SEM (b), standard error of the mean of b. 
R2, coefficient of determination. 
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The dynamic measurement of FFA yield by 1H NMR is a promising method in 
determining the rate of gastric lipolysis in an in vitro system, as well as enabling analysis 
in small volumes where availability of enzymes may be limited. However, the volume 
limitation of the NMR analysis may itself skew digestion behaviour. Digestion tests for 
the determination of lipolytic rate conducted in NMR were different from the simulated 
gastric system in the previous studies. Due to the difference in the volume range of the 
two in vitro systems, the rate of the reaction determined by 1H NMR analysis may not 
represent the rate of lipolysis in the simulated gastric system. Therefore, future work will 
need to combine GC method with 1H NMR to find the correlation of the two in vitro 
systems. 
4.4 Discussion 
1H NMR has previously been reported to be an appropriate analytical method for 
measuring the rate of lipolysis. Madden et al. (1993) used 1H NMR to relate methylene 
peak area to the triglycerides combined with a biochemical assay to quantify triglyceride 
lipolysis in triacylglycerol metabolism in the rat heart. Nieva-Echevarría et al. 
(2014)proposed using 1H-NMR spectra to quantify triglycerides, partially glycerol and 
free fatty acids from the matrix of the complex lipid system. More recently, Lolli et al. 
(2018) used similar 1H NMR spectra method as in the study from Nieva-Echevarria et al. 
(2014) and combined with gas chromatography-mass spectrometry (GC-MS) to quantify 
cyclopropane fatty acids in Grana Padano cheese.  13C and 31P NMR have also been used 
to study mono-, di-glycerides and fatty acids in some studies (Gusntone, 1991; Ng, 2000; 
Spyros & Dais, 2000; Vlahov, 1996). Those studies provide valuable information for 
quantification of lipolysis in the gastric digestion. However, these tests were all conducted 
in the isolated oil phase or using extractions in the organic solvents. None of the studies 
reviewed has determined emulsion lipolysis dynamically as part of an in vitro system, nor 
has research been undertaken to analyse digesta from human subjects. 
In this study, we wanted to obtain the signal change of the -COOH group from when free 
fatty acids were generated from the hydrolysis of triglycerides under dynamic conditions. 
The proton changes of the -OH group of glycerol in the aqueous phase was considered to 
be able to be minimised at the beginning of the study. However, the results later proved 
that this proton exchange was significant and could not be neglected. 
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The use of oleic acid as an internal standard for the design of dynamic gastric digestion 
tests was proven to be inappropriate as the addition of oleic acid could not blend well 
with the initial digestate. The phase separation made it difficult for the detective coil in 
1H NMR to capture the correct signal and it was assumed the major cause of this issue. 
In addition, the stickiness of oleic acid has made the installation of the plunger impossible 
to avoid involving air bubbles in the sample. This as well deteriorated the accuracy of 
data gathering. 
As suggested by some of the studies (Nieva-Echevarría et al., 2014; Nieva-Echevarría et 
al., 2015), monitoring the signal changes of the -CH2 group next to the glycerol backbone 
of the triglycerides might give better quantification of the lipolytic products as well as the 
extent of lipolysis. However, the use of appropriate standard compounds and the 
development of a calibration curve would still need to investigate in the future. 
One of the major hurdles in our study was the accurate quantification of the lipolytic 
products while enzymes were still reacting in the system. The objective of the study was 
to measure the dynamics of simulated gastric digestion in the 1H NMR unit in real-time. 
This required the lipolytic products to be analysed in the mixture of digestate rather than 
in single phase (pure oil, aqueous solutions, or extractions in proper solvents). As samples 
in single phase would get the best of the signals than in multiple phases for 1H NMR unit, 
the accuracy of the signal would be compromised under conditions in this simulated 
digestion. Additionally, as discussed earlier, as lipolysis proceeded, the mixture of mono-, 
di-, and triglycerides and fatty acids showed a tendency to cream to the top of the sample 
and exceed the detectable range of the coil in the 1H NMR unit. Signals from the mixed 
compounds might partially be lost due to this reason. Considering the inherent challenges 
in using 1H NMR as a tool for dynamic analysis of lipolysis under in vitro gastric 
conditions, coupled with the time taken to develop the approach, and the 
acknowledgement that without appropriate validation, any results generated may be an 
inaccurate reflection of the actual lipolysis. It was decided to halt the development of this 
methodology and focus on more widely established techniques, namely the GC method. 
4.5 Conclusions and recommendations 
In conclusion, the 1H NMR spectroscopy that has been used in this chapter may be a 
promising innovative method to dynamically analysis the changes of lipid digestion in 
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the simulated gastric environment. However, still, several issues need to be addressed 
before further application. 
To recommend possible solutions, as mentioned earlier, the use of soluble short-chain 
fatty acids in order to generate a suitable calibration curve may be applied. Additionally, 
more work needs to be done to calculate the correspondent shear rate within the reaction 
tube with a spinning stirrer. Another issue that needs notice is that the tube used for 1H 
NMR spectroscopy has a plunger on the top space of the sample to expel air. It was very 
challenging to appropriately insert the plunge due to the adhesive properties of the 
digestive mixture. Moreover, in order to minimise the influence of phase separation 
occurred in the process of lipolysis, a selection of specific 1H NMR tubes needs to be 




Chapter 5 Digestion of protein emulsions using a 
simulated neonatal gastric system 
5.1 Introduction 
The immaturity of the GI tract environment in newborns can be consequential in 
compromising the effectiveness of lipid digestion in the small intestine, leading to a 
greater reliance on gastric digestion relative to adults. Arguably, infant digestion is 
biologically predisposed towards digestion of a singular food, i.e. milk. However, the 
availability of infant formula as an alternative to maternal milk may lead to differences 
in the manner and effectiveness by which these are digested, noting that infant formulae 
have distinct differences in structure and composition to breast milk. 
Certainly, in the case of lipid digestion, human trials have shown that maternal milk 
appears more efficiently digested than infant formulae. Compositional differences in lipid 
and protein types and pronounced variations in droplet interfacial layer composition and 
structure are considered to have a significant impact on the dynamics of gastric lipid 
digestion of maternal milk and infant formulae. Such differences are likely a consequence 
of processing methods such as pasteurisation and homogenisation. In particular, the 
subsequent stabilisation of formulated emulsion droplets with a milk protein adsorbed 
layer is speculated as influencing the ability of droplets to be hydrolysed by endogenous 
lipase enzymes (de Oliveira, Bourlieu, et al., 2016; de Oliveira, Deglaire, et al., 2016; 
Gallier et al., 2013). In response to such hypotheses, recent studies have explored the use 
of membrane fractions extracted from milk fat globules, which were found to have an 
impact on lipase adsorption (Bourlieu-Lacanal et al., 2015). 
However, it is still not fully established whether, or how, the structural differences of the 
maternal milk and infant formula emulsions influence the lipid digestion process.  
Previous in vitro studies have shown different structural outcomes during the gastric 
digestion of maternal, formulated and model milk emulsions, but these were not 
correlated with the dynamics of lipolysis. This study attempts to determine whether 
lipolysis during gastric digestion is influenced by the emulsion structure using a static in 
vitro gastric model.  In order to study how the interfacial compositions and properties 
could influence the digestibility of infant milk, a model emulsion system was developed 
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comprising a phospholipid stabilised emulsion that could be protein-coated using 
lactoferrin. This would allow the digestion of emulsions of equivalent lipid composition 
and droplet size, but with variable interfacial compositions to be studied. To further 
explore the role of protein adsorption on the kinetics of lipolysis, gastric digestion was 
carried out with both fungal lipase and pepsin present, as well as with the individual 
protease and lipase. In this way, any co-dependency of enzyme action on hydrolysis of 
either interfacial layer or lipid substrate could be determined. Analysis of lipolysis rates 
of the reaction was conducted using GC, while SEM and TEM were used to determine 
the impact of gastric digestion conditions on the structure of emulsion droplets during 
gastric incubation. 
5.2 Materials and Methods 
5.2.1 Materials 
A scheme of model protein emulsions is shown below. 
 
Figure 5.1 A, Intralipid, a phospholipid coated soybean oil emulsion; B, lactoferrin coated 
Intralipid. 
All the other materials were described in Chapter 3.1. 
5.2.2 In vitro digestion using Intralipid model emulsions 
Intralipid was used as a model emulsion system to establish the appropriateness of the in 
vitro model and the associated characterisation of the simulated digestion. This is a 
commercial product that shows very stable emulsion properties and consistency where 
soybean oil droplets are stabilised by a monolayer of phospholipids from egg lecithin. A 
final 3.6 % (v/v) oil/water emulsion was achieved by diluting Intralipid emulsion with 
Milli-Q water, to mimic the fat content encountered in standard infant formulae. 
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The initial digestate was prepared by mixing a diluted Intralipid emulsion containing 3.6% 
(w/v) fat or Intralipid emulsion containing 3.6% (w/v) fat and 1% (w/v) of lactoferrin as 
the substrate, and SGF at a ratio of 20:50 v/v. In this experiment, the volumes of diluted 
Intralipid and SGF (without the enzymes) were 40 ml and 100 ml, respectively. 
In this experiment, the volumes of diluted Intralipid and SGF were 40 mL and 100 mL, 
respectively. The mixtures were then kept in a water bath for around 10 min until they 
reached a temperature of 37 ⁰C. 
An amount of 450 mg of dry powdered porcine pepsin (800-2500 units/mg protein) and 
20 mg of dry powdered Rhizopus oryzea lipase (80 U/mg) was first hydrated with a small 
amount of Milli-Q water (usually 5 to 10 times of the enzymes own weight) and then 
added to the mixture. The mixture was incubated at 37 ⁰C till 120 min with stirring rate 
of 10 rpm. Starting from 0 min and in every 15 min, an amount of 50 µL, 1.5 mL or 1 mL 
of two aliquots was sampled for measurements such as ζ-potential, droplet size 
measurement or confocal microscopy observation. 
5.2.3 Analysis of lipolysis products by GC 
Lipid extraction 
The extraction process referred to the method in Helbig et al. (2012) with small 
modifications. An aliquot of 0.5 mL sample was taken during the in vitro digestion at 0, 
15, 30, 45, 60, 90, 105, and 120 min. Each sample was poured into a Kimax tube 
containing a mix of solvents (1 mL ethanol, 1.5 mL of 1:1 (v/v) diethyl ether and heptane, 
and 0.1 mL of sulphuric acid (2.5 M)).  Each tube was mixed by vortex for about 1 min 
and centrifuged for another 5 min at 1000 × g at room temperature. The supernatant from 
each tube was carefully removed and transferred to another Kimax tube. The residual 
lipidic fraction in the first Kimax tube was extracted with 1 mL of 1:1 (v/v) diethyl ether 
and heptane again following the previous procedure. The collected supernatant of the two 
extractions was brought up to 3 mL with 1:1 (v/v) diethyl ether and heptane. Then 300 
mg of anhydrous sodium sulphate was added into each tube to dry any water residue. 
About 1 mL of the dried supernatant was carefully transferred to a GC sample vial for 
further analysis. 
Validation of the GC instrument 
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See Chapter 3.2.4. 
GC analysis 
See Chapter 3.2.4. 
5.2.4 Scanning electron microscopy (SEM) 
See Chapter 3.2.5. 
5.2.5 Transmission electron microscopy (TEM) 
See Chapter 3.2.6. 
5.2.6 Statistical Analysis 
In this study, free fatty acids have been used as markers of the degree of lipid digestion. 
On the GC chromatograms, the area under the peaks of total FFA was measured 
throughout digestion. In this study, as there was no internal standard involved, calibration 
curves of pure myristic and palmitic acid (FA C14:0 and C16:0) were used to determine 
the concentration of FFA (See calibration curves in 3.2.4). As the carbon number of the 
primary FFA released from soybean is in the range 8 to 18, and the theoretical response 
correction factors of fatty acids from C8 to C24 are very similar (0.96-1.19) (Christie & 
Han, 2012). Therefore, we treated the response factor of each type of fatty acid released 
from our model emulsion as 1. This showed that the area under the peak (AUP, mV*min) 
was in proportion to the sample concentration (g/L). Thus, we used AUP instead of 
concentration to provide an empirical representation of the dynamics of the lipolysis 
process. 
In order to compare the rate of lipolysis from different treatment without internal standard 
involved, we normalised the original data of AUP and results were shown in Figure 4.4. 
The z-score for each AUP value is 
𝑧 =
𝑥 − 𝑥 
𝑆
 
Where z-score is the normalised AUP value; x is the AUP value of the sample; x̅ is the 




5.3.1 Increase of free fatty acids (FFA) from a model emulsion in a 
simulated gastric digestion 
The d43 of diluted Intralipid at pH 7 was 0.32 μm (before digestion). The value for 
lactoferrin coated Intralipid was 0.4 μm. The ζ-potential of the Intralipid emulsion (3.6%, 
v/v) was -44.06 mV at pH 7 whereas for the lactoferrin coated Intralipid emulsion the 
value was +16.6 mV at neutral pH. The droplet size and surface charge data were done 
in a previous study (Lueamsaisuk, 2015). The extent of lipolysis for Intralipid model 
emulsions digested in different pH levels and enzyme treatments was around 20% (w/w) 
of total triglycerides (Figure 5.2) estimated using the standard curve in Chapter 3.2.4. 
This figure was within the range of degree of lipolysis (10-30%) observed in the previous 
in vivo study (Carriere et al., 1993) 
 
Figure 5.2 GC analysis on FFA released relative to total potential FA from the triglycerides from 
Intralipid model emulsion in a simulated gastric system. CL, Intralipid digested with lipase 
alone; CLP, Intralipid digested with lipase and pepsin; LfL, lactoferrin coated Intralipid digested 
with lipase alone; LfLP, lactoferrin coated Intralipid digested with lipase and pepsin. The pH 














FFA released relative to total potential FA from the triglycerides (%)
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Figure 5.3 showed the original AUP for each treatment. From observation, the digestate 
of Intralipid itself with lipase or lipase and pepsin did not have visible phase separation 
during 120 min of simulated digestion. However, when Intralipid was coated with 
lactoferrin, the digestate showed aggregations from 30 min and onwards. This made 
sampling problematic as the digestate became increasingly inhomogeneous. It also 
confirmed that in this study, without an internal standard in each experiment, the high 
degree of variation was most likely due to issues with sampling. 
 
Figure 5.3 FFA increase of original AUP values of each in vitro digestion treatment. A, Intralipid 
digested with lipase; B, Intralipid digested with lipase and pepsin; C, lactoferrin coated 




Figure 5.4 Normalised FFA increase from original AUP values for each in vitro digestion 
treatment. A, Intralipid digested with lipase; B, Intralipid digested with lipase and pepsin; C, 
lactoferrin coated Intralipid digested with lipase; D, lactoferrin coated Intralipid digested with 
lipase and pepsin. Solid line, linear regression; dash line, 95% confidence interval.  
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Table 5.1 Parameters of linear regression from normalised FFA increase (α=0.05). 

























-0.801 -0.968 -0.955 -1.011 -0.899 -0.968 -1.500 - -1.059 -0.679 -0.492 -0.894 
SEM (a) 
0.117 0.202 0.143 0.074 0.079 0.062 0.250 - 0.165 0.339 0.359 0.185 
b 
0.027 0.014 0.016 0.019 0.024 0.022 0.022 - 0.012 0.012 0.017 0.013 
SEM (b) 0.002 0.003 0.002 0.001 0.001 0.001 0.003 - 0.003 0.005 0.005 0.003 
df 1;25 1;26 1;28 1;28 1;28 1;25 1;24 1;27 1;27 1;25 1;24 1;26 
F 
277.625 23.849 57.494 310.299 414.907 514.781 39.833 1.150 21.350 6.726 11.744 24.717 
Sig. 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.293 <0.001 0.016 0.002 <0.001 
R2 
0.918 0.478 0.672 0.917 0.937 0.954 0.624 - 0.442 0.212 0.329 0.487 
CL, Intralipid digested with lipase alone. 
CLP, Intralipid digested with lipase and pepsin. 
LfL, lactoferrin coated Intralipid digested with lipase alone. 
LfLP, lactoferrin coated Intralipid digested with lipase and pepsin. 
a, intercept value. 
SEM (a), standard error of the mean of a. 
b, slope value. 
SEM (b), standard error of the mean of b. 
df, degrees of freedom and residual degrees of freedom. 
F, F value. 
R2, coefficient of determination.
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The normalised data of increase of FFA was shown in Figure 5.4. As the normalised data 
for each treatment shown in Figure 5.4 were very noisy. Several statistical methods on 
the same data set were applied to attempt to resolve the large variation of the data in each 
treatment. 
5.3.1.1 Linear regression 
Linear regression was first applied to the normalised data in Figure 5.4 and Table 5.1. 
The data confirmed that there were significant increases with time for all of the treatments 
except for lactoferrin coated Intralipid digested with lipase alone at pH 4.5. There was 
also no significant difference between the slope values of the relative rate for each 
treatment when linear regression was applied to data for the first 30 min (see Appendix 
A2). However, linear regression was not proper since the normal probability plot of the 
residue for each treatment deviated from the diagonal line (graphs not shown). As the 
data was very noisy for most of the treatments, it was also challenging to apply models 
or curves to describe the trends of the data. 
Except for the treatment of Intralipd digested with lipase alone (Figure 5.4 A), the other 
treatments (Figure 5.4 B, C, and D) showed a curvilinear trend. Because of the large 
variations of the data, it was also very challenging to apply a non-linear curve model on 
each treatment (data not shown). 
5.3.1.2 Repeated-measures ANOVA for digestion time 
One-way repeated-measures ANOVA was also applied to the same set of data to check 
whether there was any significant difference for the within-subject⸺time. The 
probability of the repeat-measures ANOVA was shown in Table 5.2. The results showed 
that for the digestion of Intralipid emulsion, except for pH 4.5 digested with lipase alone, 
FFA showed a significant increase for all the other treatments. However, for the digestion 
of lactoferrin coated Intralipid emulsion, there was no significant increase for FFA during 
120 min of simulated digestion. 
As noted, the repeatability of some of the treatments shown in Figure 5.4 was not good. 
For example, in treatment pH 4.5 Intralipid digested with lipase alone, and all treatments 
for lactoferrin coated Intralipid digestion, the replicates in each treatment showed 
different trends which made statistical method difficult to interpret. This indicated that 
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our experimental method was not repeatable due to difficulties in sampling from the 
phase-separating digestate. 
Table 5.2 Probability table of repeated-measures ANOVA for normalised FFA increase. 
 
Repeated Measures ANOVA 
pH 3.5 CL 0.006 
pH 4.5 CL NS 
pH 5.5 CL 0.038 
pH 3.5 CLP 0.001 
pH 4.5 CLP 0.001 
pH 5.5 CLP 0.030 
pH 3.5 LfL NS 
pH 4.5 LfL NS 
pH 5.5 LfL NS 
pH 3.5 LfLP NS 
pH 4.5 LfLP NS 
pH 5.5 LfLP NS 
CL, Intralipid digested with lipase alone. 
CLP, Intralipid digested with lipase and pepsin. 
LfL, lactoferrin coated Intralipid digested with lipase alone. 
LfLP, lactoferrin coated Intralipid digested with lipase and pepsin. 
The grade shade showed no significant difference in the data after specific time points. 
NS, no significant difference. 
5.3.1.3 Repeated-measures ANOVA for a two-way interaction between pH and 
time, and a three-way the interaction between of enzyme treatment, pH and time 
As repeated-measures ANOVA showed, there was a significant increase with time for 
treatment of Intralipid digested with lipase alone or with lipase and pepsin. A mixed two-
way ANOVA was applied to explore whether there was a significant difference between 
the interaction term “time*pH level”. There was a significant interaction [F(4.273, 10.682) 
= 5.734, p = 0.010, partial η2 = 0.696, ε = 0.267] between the pH level and time in FFA 
increase from the treatment of Intralipid digested with lipase alone. This indicated that 
pH did have a significant effect on the production of FFA under such treatment. For the 
treatment of Intralipid digested with lipase and pepsin, there was no significant interaction 
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(p > 0.05) between the pH level and time in FFA increase. This indicated that under this 
treatment, pH did not have a significant effect on the production of FFA. 
When another between-subject factor “enzyme” (treatment with lipase or lipase and 
pepsin) was involved in the repeated-measures ANOVA test, there was a significant 
three-way interaction between enzyme, pH level and time [F(5.960, 29.802) = 6.272, p < 
0.0005, partial η2 = 0.556, ε = 0.426]. There was a significant two-way interaction 
between pH level and enzyme [F(2, 10) = 8.509, p = 0.007]. All other two-way 
interactions (pH*time or enzyme*time) showed no statistical significance (p > 0.05). 
There was a significant simple main effect of enzyme at the pH 4.5 [F(1, 10) = 9.853, p 
= 0.010], but not at pH 3.5 or pH 5.5 (p > 0.017, statistical significance of a simple main 
effect was accepted at a Bonferroni-adjusted α level of 0.017, α = 0.05/3, as there were 
three pH levels, i.e. three main effects). This indicated that the enzyme treatment, i.e. 
whether pepsin was present in the digestate might have a significant impact on the 
increase of FFA at pH 4.5. 
A mixed two-way ANOVA was also applied to explore whether there was a significant 
difference between the interaction term “time*pH level” for treatment of lactoferrin 
coated Intralipid digested with lipase or lipase and pepsin, though there was no significant 
difference in digestion time when looking at individual treatment. For the treatment of 
lactoferrin coated Intralipid digested with lipase alone, there was no significant 
interaction (p > 0.05) between the pH level and time in FFA increase. There was also no 
significant interaction (p > 0.05) between the pH level and time in FFA increase when 
pepsin was present in the system during digestion. This indicated that pH might not have 
a significant effect on the FFA increase during digestion for the treatment of lactoferrin 
coated Intralipid. 
When involving another between-subject factor “enzyme” (treatment with lipase or lipase 
and pepsin) in the repeated-measures ANOVA test, there was no significant three-way 
interaction between enzyme treatment, pH level and time (p > 0.05). And all two-way 
interactions (pH*time, enzyme*time or enzyme*pH) showed no statistical significance 
(p > 0.05). 
When considering the effect of lactoferrin coating on the Intralipid emulsion interface 
with same enzyme treatment, there was no significant three-way interaction between 
76 
 
lactoferrin coat, pH level and time (p > 0.05) for digestion with lipase alone. There was a 
significant two-way interaction between time and pH level [F(4.779, 21.507) = 7.605, p 
< 0.005, partial η2 = 0.628, ε = 0.341]. All other two-way interactions (lactoferrin 
coat*time or lactoferrin coat*pH) showed no significant difference (p > 0.05). There was 
a significant simple main effect of the enzyme at the 120 min [F(2, 9) = 11.357, p = 0.003], 
but not at other time points from 15 to 120 min (p > 0.006, the statistical significance of 
a simple main effect was accepted at a Bonferroni-adjusted α level of 0.006, α = 0.05/8, 
as a selection of 8-time points from 15 to 120 min was used in this test, i.e. eight main 
effects). There was also no significant three-way interaction between protein coat, pH 
level and time (p > 0.05) for digestion with lipase and pepsin (p > 0.05). Moreover, there 
was no significant difference (p > 0.05) for all two-way interaction under this enzyme 
treatment (pH*time, lactoferrin coat*time or lactoferrin coat*pH). It indicated that 
lactoferrin coat and pH might not have a significant impact on the generation of FFA 
during digestion. 
5.3.2 Morphological changes of emulsion droplets during simulated 
gastric digestion using SEM 
Images under SEM during digestion obtained at pH 3.5 was shown in Figure 5.5. The 
emulsion droplets were embedded in agarose structure. Droplets had a round shape and 
smooth surface at the commencement of simulated gastric digestion (Figure 5.5 A, C and 
E). The surface structure of the Intralipid droplets digested in the presence of lipase alone 
was greatly altered throughout digestion, with noticeable dimpling evident at the interface 
(Figure 5.5 B). 
Intralipid droplets coated with lactoferrin digested at pH 3.5 with lipase only did not show 
significant changes in size from the beginning to the end of digestion (Figure 5.5 C and 
D). Some surface dimpling was observed, but not to the same apparent extent to the 
lipase-digested uncoated emulsion. For the digestion of Intralipid coated with lactoferrin 
at pH 3.5 with lipase and pepsin, droplet size was seen to increase throughout digestion. 
Additionally, some of the large droplets had distinctive erosion patterns appearing at the 
interface. Other droplets were seen to display similar dimpling patterns similar to the 
uncoated emulsion after lipolysis. This surface dimpling has been reported previously, 
presenting comparison to studies by Pafumi et al. (2002) and Gallier et al. (2013). The 
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image results showed that the morphology of the emulsion droplets had changed during 
the simulated gastric digestion. 
 
Figure 5.5 SEM images of emulsion droplets during 120 min of simulated gastric digestion at 
pH 3.5. A and B, droplets of Intralipid digested with lipase alone at 0 and 120 min; C and D, 
droplets of Intralipid coated with lactoferrin digested with lipase alone at 0 and 120 min; E, 
droplets of Intralipid coated with lactoferrin digested with lipase and pepsin at 0 min; F-J, 
droplets of Intralipid coated with lactoferrin digested with lipase and pepsin at 120 min.   
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5.3.3 Morphological changes of emulsion droplets during simulated 
gastric digestion using TEM 
Intralipid emulsion droplets did not show any notable difference in the size at the 
commencement of digestion regardless of enzyme composition or pH (Figure 5.6 A1, 
B1and C1, Figure 5.7 A1, B1 and C1). The oil droplets had a diameter of 0.3-0.5 µm (in 
agreement with previous SEM data) and showed stability against flocculation at all pH 
levels studied. However, at the end of the simulated digestion process, the morphology 
of most of the oil droplets had changed with the final structure varying according to 
relative pH. At pH 3.5, they formed clusters with individual droplets displaying a high 
degree of anisotropy. Oil droplets appeared smaller and darker with the bright area inside 
the droplets, showing electron-dense and less dense regions generated during two hours 
of digestion (Figure 5.6 A2-A5). At pH 4.5, the appearance of the droplets was more 
uniform, noting that some electron-dense regions had accumulated at the inner surface of 
the droplets (Figure 5.6 B2-B4). The appearance of the large droplets (diameter larger 
than 5 µm) was indicative of coalescence, with less electron-dense compounds forming 
in round shape inside the large droplets (Figure 5.6 B4 and B5). At pH 5.5, some degree 
of anisotropy was observed, along with regions of highly disordered structures (Figure 
5.6 C2-C5). Although these regions showed appreciable staining, it is difficult to 
determine whether these are lipids based due to the irregularity of the appearance. 
For Intralipid emulsion digested with lipase and pepsin, the oil droplets at the initial state 
were shown in Figure 5.7 A1, B1 and C1. After two hours of digestion, oil droplets at pH 
3.5 and 4.5 became larger. Some were merged into giant droplets with a diameter larger 
than 5 µm. At pH 3.5 in particular, the surface of the large droplets became diffuse and 
cracked (Figure 5.7 A2-A5, B4 and B5). Vesicles formed inside the large droplets with 
electron-dense regions observed inside the vesicles (Figure 5.7 A3, B2 and B3) and then 
released to the ambient aqueous phase (Figure 5.7 B4 and B5). Some of the striated 
structure were generated during simulated gastric digestion, attached on the droplet 
surface and then released into the ambient phase (Figure 5.7 B4 and B5). At pH 5.5, some 
others tended to break up and release the electron-dense compounds accumulated inside 
the droplets (Figure 5.7 C2-C5). The compounds formed inside the droplets accumulated 
in round beads and turned out to be very different in shapes from the droplets digested at 
pH 3.5 and 4.5 after two hours. Changes in the morphology of the droplets were more 
drastic when pepsin was included in the digestion process compared to when there was 
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lipase present alone. Additionally, striated structure compounds only formed in the 
combined presence of pepsin and lipase. 
When Intralipid emulsion droplets were coated with lactoferrin on the interface, droplets 
became aggregated at the commencement of digestion, with protein layer seen to located 
on the interface (Figure 5.8 A1, B1 and C1). Because of the contrast effect from the 
protein layer, droplets could be observed much more clearly under TEM. When lipase 
was present in the digestate alone, the size of the droplets did not change drastically after 
two hours of digestion at pH 3.5 (Figure 5.8 A2-A5). Electron-dense compounds 
appeared at the inner interface of the oil droplets (Figure 5.8 A2), and the droplets were 
increasingly less spherical (Figure 5.8 A3-A5). At pH 4.5, droplets had increased in size 
and appeared amorphous after two hours of digestion (Figure 5.8 B2-B5). Droplets at pH 
5.5 showed diverse structural characteristics. Spherical droplets were still observed, but 
the staining patterns within these droplets had become distinctively disparate. When both 
of the enzymes (lipase and pepsin) existed in the digestate, droplets underwent many 
notable changes compared to conditions with lipase alone (Figure 5.9). Droplets were 
observed to have merged into large ones, released transparent vesicles and striated like 
electron-dense compounds and even appearing to have burst. Armand et al. (1996) also 
showed distorted droplets and electron-dense lipolytic products on infant formula gastric 
digestion in an in vivo study in the premature infant. There was not much different 





Figure 5.6 TEM images of Intralipid emulsion digested with lipase alone. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, pH 4.5 at 0 min; B2-B5, pH 4.5 at 




Figure 5.7 TEM images of Intralipid emulsion digested with lipase and pepsin. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, pH 4.5 at 0 min; B2-B5, pH 




Figure 5.8 TEM images of lactoferrin Intralipid emulsion digested with lipase alone. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, pH 4.5 at 0 min; B2-




Figure 5.9 TEM images of lactoferrin coated Intralipid emulsion digested with lipase and pepsin. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, pH 4.5 at 




In this study, we determined that lipolysis was primarily responsible for the changes to 
the morphology of emulsion droplets during this simulated gastric digestion process. 
However, correlating the observed changes in droplet structure to the rate and extent of 
lipolysis was ultimately not possible, due to challenges in obtaining reliable 
measurements for FFA content during digestion. For the GC measurements, data 
showed large variations in replicates across most of the treatments (notably those 
samples observed to undergo phase separation during the process of digestion which 
hindered reliable sampling). Accordingly, it was difficult to draw reasonable 
conclusions regarding the extent of lipolysis from the FFA data across variable pH 
conditions, presence of lactoferrin and enzyme combination.  Therefore, the GC 
measurement of FFA increase may not accurately reflect the actual reaction kinetics 
from the digestion process. The statistical analysis of linear regression for the first 30 
min showed that the rate (the slope values) of lipolysis had no significant difference 
among all treatments. However, the data set showed that linear regression might not be 
a suitable way to describe the trend of lipolysis in all treatments across the overall 
reaction time. Since the errors in the experiment were remarkably large, it was also 
challenging to apply non-linear regression in order to describe the trend of FFA 
increase. 
Findings can be considered concerning two studies by Lueamsaisuk et al. (2014, 2015) 
that had previously shown that the particle size distributions of emulsions comprising 
Intralipid and lactoferrin (as used in this current study) were affected by both pH 
conditions and combination of pepsin and lipase during simulated digestion over 120 
min (critical findings from this study were reproduced in Figure 5.10 and 5.11). The 
release of FFA was not measured in these previous studies, so it was not possible to 
unequivocally state that structure dynamics were a consequence of lipolysis. However, 
it was hypothesised that emulsions not displaying any changes in emulsion structure 
during digestion were potentially not undergoing lipolysis. In this current study, we 
confirmed the liberation of FFA for all samples regardless of whether the interfacial 
layer comprised phospholipid or phospholipid bound to lactoferrin. This would appear 
to confirm that the presence of interfacial protein for these emulsions was not entirely 
inhibitory to lipolysis when pepsin was excluded from the digestate (i.e. negating the 
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hypothesis that proteolysis of the interface is a requisite for lipolysis to occur for protein 
stabilised emulsions).  
In further considering the relationship between structural changes observed during 
digestion and lipolysis, it was interesting to note that the electron-dense structures found 
near the surface of droplets after digestion (Figure 5.6-5.9) appeared independent of the 
inclusion of pepsin in the digestate, pH changes, or the curve shape of the FFA increase.  
Similar structures have been observed in previous studies (Armand, Hamosh, et al., 
1996; Gallier et al., 2013), with the suggestion that these are polar crystal lipolytic 
products generated from triglyceride hydrolysis. Variance in the extent of structural 
changes observed in both SEM and TEM under different pH conditions may be due to 
variations in the activities of both pepsin and lipase across this pH range. Additionally, 
differences in droplet structure and morphology may also possibly be due to the impact 
of pH on the assembly of the lamellar polar lipid structures, noting that lower pH 
conditions will increasingly approach the pKa of the fatty acids being liberated and thus 
increasingly lead to protonation of these molecules. 
However, results (both microscopic and GC) would ultimately suggest that the 
lactoferrin layer bound to the Intralipid oil droplets did not appear to act as a barrier for 
lipase binding. A study on interfacial protein structure provided similar results 
(Maldonado-Valderrama et al., 2013). This suggested that there were gaps in the 
oil/water interface where the hydrophobic domain of lipase could access to the 
phospholipid layer, and thus bind to the interface. Subsequent liberation and adsorption 
of free fatty acids from lipolysis might then be expected to displace bound protein from 
the interface, thereby enabling further adsorption of lipase. 
In our initial hypothesis, gastric lipolysis kinetics of protein stabilised emulsions are 
optimised by a co-dependency between pepsin and lipase. Pepsin would facilitate 
lipolysis by hydrolysing the adsorbed protein layer, partially removing the barrier for 
lipase to attach on the phospholipid-oil interface, more effectively enabling lipase 
binding and thus increasing the rate and extent of lipolysis. However, the addition of 
pepsin did not appear to change this scenario. This may occur due to several reasons. 
Firstly, as the isoelectric point of lactoferrin is 8.7 (Sánchez, Calvo, & Brock, 1992), 
lactoferrin carries positive charges from pH 3.5 to 5.5. The pH level could have a 
substantial impact on the charge density of proteins as it affects the degree of ionisation 
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of proteins. Therefore, when pH increases from 3.5 to 5.5, the charge density of 
lactoferrin decreases. This may loosen the attachment of lactoferrin to the interface 
covered by negatively charged phospholipids where lipase could more easily overcome 
the protein barrier and adsorb on the oil/water interface without the help of pepsin. 
Secondly, as pH level dropped from 5.5 to 3.5, pepsin activity would be seen to increase 
towards its optimum at pH = 2.0, increasing proteolysis and liberating more peptides. 
Hydrolysed hydrophobic peptides may serve to reduce the surface tension on the 
oil/water interface and induce emulsion instability through either flocculation and/or 
coalescence. For example, a study (Schröder, Berton-Carabin, Venema, & Cornacchia, 
2017) showed emulsion droplets stabilised by whey protein had stronger interfaces with 
higher elasticity than hydrolysed proteins. Sarkar et al. (Sarkar, Goh, Singh, & Singh, 
2009) also found emulsion droplets stabilised by β-lactoglobulin had extensive 
flocculation and coalescence in the in vitro gastric digestion. Such destabilisation result 
may usually lead to an increase of droplet size and reduction in surface area for lipase 
adsorption. Separating the particular roles of pepsin and lipase on lipid hydrolysis 
kinetics has been found to be particularly challenging both due to the profound changes 
in emulsion structure during digestion and as a consequence of the disparate optimum 
activities displayed by both enzymes. Arguably, the results would be better interpreted 
if the sampling problem could be resolved with an internal standard induced for GC 
analysis. 
That said, it is worth noting that changes to emulsion droplet size relative to FFA 
release have been observed in several earlier studies, although the separation of lipases 
and pepsin was not considered in these studies (Armand, Borel, et al., 1994a; Armand et 
al., 1999; Bourlieu et al., 2017; de Oliveira, Deglaire, et al., 2016; Luo et al., 2019; 
Pafumi et al., 2002). Some of this previous research (Armand, Borel, et al., 1994a; 
Bourlieu et al., 2017; de Oliveira, Deglaire, et al., 2016; Luo et al., 2019; Pafumi et al., 
2002) also found the release of FFA reached a plateau status after 20 to 60 min after the 
initiation of gastric digestion (in vitro and in vivo). This indicated that the reaction 
might reach equilibrium or that the lipolytic products had inhibited the lipase activity at 
the first hour of gastric digestion (Pafumi et al., 2002). The study by Pafumi et al. 
(2002) showed that lipases were trapped in the protrusions formed by lipolytic products 
on the oil/water interface and therefore inhibited lipolysis. 
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These findings were somewhat different from what was observed in this study. One of 
the reasons, as stated above, was the difficulty in sampling. The large standard errors 
were also seen in those studies. It should be noted that lipolysis takes place at the oil/water 
interface which is very different from the conventional enzymatic reactions in the aqueous 
environment following Michaelis-Menten kinetics. Therefore, it could be very possible 
that the concentration of FFA from the lipolysis in this study has not yet reached the 
saturation point for product inhibition, also noting that this study utilised a fungal lipase 
as an analogue for human gastric lipase, and therefore may not provide full equivalence 
regarding the type and concentrations of FFA released. 
5.5 Conclusions 
In conclusion, the rate of FFA during simulated gastric digestion was not able to be 
correlated to the differences in structural changes and droplet size as a consequence of 
emulsion and simulated gastric fluid composition. However, the observation of FFA 
synthesis for all measurements was able to indicate that lactoferrin (protein) coating on 
the Intralipid surface did not appear to provide a barrier to the hydrolysis by lipase, 
although it did result in different emulsion structural pathways during digestion. The 
inconclusive nature of the GC findings relative to emulsion structure dynamics during 
digestion was believed to be a consequence of phase separation of particular 
compositions during digestion, which rendered accurate sampling difficult. To address 







Figure 5.10 Droplet size distribution of Intralipid emulsion in a simulated infant gastric system, 
adapted from Luemsaisuk et al. (2015). A, Changes in the droplet size distribution during 
digestion with fungal lipase and pepsin for 120 min; B, Changes in d32 during digestion with 
fungal lipase and pepsin, pepsin alone, and lipase alone for 120 min. Emulsions were treated 




Figure 5.11 Droplet size distribution of lactoferrin coated Intralipid emulsion in a simulated 
infant gastric system, adapted from Luemsaisuk et al. (2015). A, Changes in droplet size 
distribution during digestion with fungal lipase and pepsin for 120 min; B, Changes in d32 
during digestion with fungal lipase and pepsin, pepsin alone, and lipase alone for 120 min. 




Chapter 6 Digestion of a powder infant formula using a 
simulated neonatal gastric system 
6.1 Introduction 
The rationale for this study was to progress findings from Chapter 4 and attempt to 
determine the separate and combined role of lipase and pepsin in the process of gastric 
lipolysis of formula emulsions. As discussed in the literature review, until recently, many 
prior in vitro studies exploring lipid digestion did not tend to include gastric lipase as part 
of the gastric stage of digestion. Partly this has been due to limitations around the 
availability of human gastric lipase or appropriate mammalian analogues, along with 
concerns about the functional equivalence of fungal alternatives. Additionally, the fact 
that previous clinical trials have determined that about 10-30% lipid hydrolysis occurs in 
the stomach (Armand, Borel, et al., 1994b; Armand, Borel, et al., 1996b; Armand et al., 
1999; Fave et al., 2004) has tended to provide a rationale that the gastric stage of lipid 
digestion can be overlooked in the in vitro models. Fortunately, this view is now changing. 
However, as indicated in the literature review, gastric lipolysis is viewed as providing a 
more significant role in lipid digestion for neonates and provides crucial contribution 
ensuring effective digestion and metabolism of milk fat for infants at the very early stages 
of life. 
There have been many additional discussions on the differences in properties (both 
nutritional and structural) between infant formulae and maternal milk over the decades 
(Carnielli et al., 1996; Hageman et al., 2019; Jensen et al., 1992; Jensen et al., 1978; 
Lönnerdal, 2014; López-López et al., 2001; Michalski et al., 2005; Zou, Ali, Abed, & 
Guo, 2017). Most of these have indicated that maternal milk, and notably milk fat, is 
effectively digested by infants when compared to infant formulae. While many possible 
mechanisms exist to account for variations in efficacy of lipid digestion, this study 
focusses specifically on the role of the adsorbed protein layer that provides stability to 
formulated emulsions post-homogenisation, and whether this interfacial layer is in some 
way inhibitory to the action of gastric lipase. Our previous study has determined that the 
protein did not form a barrier for lipase adsorption to a model protein stabilised emulsion 
system compared to phospholipid stabilised layer (noting that structural differences were 
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observed). However, in standard infant formulae, protein adsorption and interfacial layer 
properties are also influenced by other processing and compositional variable. 
In order to unravel the question of whether the interfacial layer of formulated emulsions 
was influential on the kinetics of lipolysis, we used a commercial infant formula as a more 
representative protein stabilised formulation. This commercial formulae consisted of the 
same amount of oil (3.5% w/v) as in Chapter 4 but comprised a different lipid and milk 
protein (whey and casein) composition. Aliquots sampled during simulated gastric 
digestion were again analysed using GC and electron microscopy to provide insights as 
to the separate and combined roles of lipase and pepsin on the rate of digestion and 
corresponding changes in droplet structure during gastric incubation. 
6.2 Materials and Methods 
6.2.1 Materials 
A scheme of infant formula is shown below. 
 
Figure 6.1 The interface of infant formula emulsion droplet which consists of a mixture of milk 
proteins and phospholipids. 
The other chemicals used in this chapter has been described in Chapter 3.1. The ingredient 
list, and protein and fat information are in Appendix A4-A7. 
6.2.2 In vitro digestion using a powder infant formula 
Infant formula dilution was prepared by adding 36 mL Mill-Q water to 5 g infant formula 
to 40 mL final emulsion with a 3.6% (w/v) fat as the substrate. It was used as a compared 
emulsion system to investigate the difference of the behaviours during simulated 
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digestion between infant formula and the Intralipid model emulsion. The ratio of this 
emulsion and SGF was 20:50 v/v. 
The initial digestate was prepared by mixing the diluted infant formula as the substrate, 
and SGF at a ratio of 20:50 v/v. In this experiment, the volumes of diluted Infant formula 
and SGF (without the enzymes) were 40 ml and 100 ml, respectively. The mixtures were 
then kept in the water bath for around 10 min until they reached a temperature of 37 ⁰C. 
The hydrated fungal lipase and porcine pepsin were then added to the mixture, and this 
was incubated at 37 ⁰C for 120 min under a stirring rate of 10 rpm. Starting from t = 0 
min, and subsequently, at intervals of 15 min, two aliquots (0.5 or 1.0 mL) were taken for 
gas chromatography, scanning electron or transmitted electron microscopy measurements. 
6.2.3 Analysis of lipolysis products by GC 
6.2.3.1 Lipid extraction 
The extraction process referred to the method in Helbig et al. (2012) with small 
modifications. An aliquot of 0.5 mL sample was taken during the in vitro digestion at 0, 
15, 30, 45, 60, 90, 105, and 120 min. Each sample was poured into a Kimax tube 
containing a mix of solvents (1 mL ethanol, 1.5 mL of 1:1 (v/v) diethyl ether and heptane, 
and 0.1 mL of sulphuric acid (2.5 M)).  Each tube was mixed by vortex for about 1 min 
and centrifuged for another 5 min at 1000 × g at room temperature. The supernatant from 
each tube was carefully removed and transferred to another Kimax tube. The residual 
lipidic fraction in the first Kimax tube was extracted with 1 mL of 1:1 (v/v) diethyl ether 
and heptane again following the previous procedure. The collected supernatant of the two 
extractions with an addition of 30 µL IS stock solution (20 g/L) was added was brought 
up to 3 mL with 1:1 (v/v) diethyl ether and heptane. Then 300 mg of anhydrous sodium 
sulphate was added into each tube to dry any water residue. An amount of 1 mL of the 
dried supernatant was carefully transferred to a GC sample vial for further analysis. The 
final concentration of IS was 0.2 g/L in the GC sample vial. 
6.2.3.2 GC instrument validation 
See Chapter 3.2.4. 
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6.2.3.3 GC analysis 
See Chapter 3.2.4. 
6.2.4 Transmission electron microscopy (TEM) 
See Chapter 3.2.6. 
6.2.5 Statistical Analysis 
As confirmed by the use of a standard curve (Chapter 3.2.5), the AUP (mV*min) was in 
proportion to the concentration of free fatty acids (g/L) in the samples. Accordingly, AUP 
was used to represent the rate and degree of gastric lipolysis.  
Pentadecanoic acid (15:0) was used as the internal standard in this study, and the AUP 
was corrected relative to the maximum value of the internal standard to compare 





Where AUP(max)internal is the maximum area under the peak value of the internal standard, 
AUP(i)internal is the area under the peak value of the internal standard in each run, and 
AUP(i) is the area under the peak value of the sample run. The increase of free fatty acids 
was indicated by corrected AUP instead. 
Limited data collection over the first 30 min of digestion meant that it was not possible 
to effectively quantify the kinetics of lipolysis in the early stages of the reaction. To 
address this issue, linear regression was instead applied to data points between 30 and 
120 min. 
Although there were traces of free fatty acids in the digestate when no enzymes were 
present, the amount was negligible as these were at least one order of magnitude below 
the value at 30 min. In order to modulate the data from 30 min and onwards, we moved 
the original point of x-axis from 0 to 30 min. Therefore, the interface of the linear 
regression with the y-axis at 30 min was able to provide an indicator as to the initial rate 
of lipolysis over the first 30 min of digestion. 
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In order to compare the differences between each pH level when infant formula was 
digested with lipase only, the Student’s t-test was used for statistical analysis. As there 
were only mean and standard errors, it was assumed that the variances of the population 
were equal (homogeneity of variances). 
6.3 Results 
6.3.1 Increase of free fatty acids in simulated gastric digestion 
The S–26 powder infant formula showed a pH of 7.23, d43 of 1.156±0.033 µm, d32 of 
0.251±0.002 µm, the specific surface area of 25.633±0.115 m2/g fat and ζ-potential of –
36.3±2.3 mV according to the previous study by Luemsaisuk et al. (2015). 
The extent of lipolysis was calculated based on the internal standard of each run (Figure 
6.2). The gastric lipolysis for infant formula was under 40% during 120 min of simulated 
digestion. The results were similar to studies in the past, which showed 10-30% of gastric 
lipolysis in neonates (Carriere et al., 1993). Except for pH 5.5 digested with lipase and 
pepsin, the extent of lipolysis increased along with elevated pH level. Moreover, the 
extent of infant formula digested with lipase only was higher than digested with lipase 
and pepsin. 
Evolution of free fatty acids was treated as the marker of the degree of lipid digestion. 
Validation of results showed consistent responses with good reproducibility from our 
method and the GC unit. The results were shown in Figure 6.3. The examples of GC 
chromatogram could be found in the Appendix A8. The statistical analysis showed that 
the data from digestion a linear relationship with time, except for formula digested at pH 
4.5 with lipase and pepsin (Table 6.1). This indicated that except for treatment at pH 4.5 
with lipase and pepsin, all other treatments had a significant increase in free fatty acids 
with time. 
The pair-wise comparison of the probability between treatments was shown in Table 6.2. 
It could be seen that the FFA increased significantly with time (Figure 6.4). From the 
probability table (Table 6.2), no significant difference in the slopes was observed between 
pH 3.5 and pH 4.5 or pH 5.5, or additionally between pH 4.5 and pH 5.5 in slopes. This 
indicated that the digestate across the three pH conditions showed no significant 
difference in the rate of lipolysis from 30 min onwards to the end of simulated digestion. 
84 
 
However, for the intercept, all three pH levels were significantly different from each other. 
This indicated that in the first 30 min, the rate of lipolysis would have been different 
among the three pH levels where the rate of pH 3.5 [a = 32.287±30.471 mV*min) < pH 
4.5 (a = 248.715±32.824 mV*min) < (a = 534.458±40.924 mV*min)]. 
 
Figure 6.2 FFA released relative to the total potential FA from the triglycerides from an infant 
formula emulsion digested in a simulated gastric system. L, infant formula digested with lipase 
alone; L+P, infant formula digested with lipase and pepsin. The pH values were all initial pH 
levels. 
 
Figure 6.3 Free fatty acid increase showed by standardised AUP (mV*min) for a powder infant 
formula digested in a simulated gastric system. A, infant formula digested with lipase alone; B, 








FFA released relative to total potential FA from the triglycerides (%)
85 
 
Table 6.1 Statistical analysis of linear regression for FFA increase under different treatments. 
 T1 T2 T3 T4 T5 T6 
a 38.287 248.715 534.458 20.690 - 67.550 
SEM (a) 30.471 32.824 40.924 12.692 - 17.764 
b 1.679 2.650 2.607 0.816 - 0.975 
SEM (b) 0.558 0.607 0.716 0.235 - 0.322 
df 1;18 1;19 1;16 1;19 1;19 1;19 
F 9.058 19.068 13.247 12.080 3.583 9.163 
Sig. 0.008 <0.005 0.002 0.003 0.074 0.007 
R2 0.335 0.501 0.453 0.389 - 0.325 
 
T1, pH 3.5 digested with lipase; T2, pH 4.5 digested with lipase; T3, pH 5.5 digested with lipase; T4, pH 
3.5 digested with lipase and pepsin; T5, pH 4.5 digested with lipase and pepsin; T6, pH 5.5 digested with 
lipase and pepsin. 
a, intercept value, unit mV*min. 
SEM (a), standard error of the mean of a. 
b, slope value, unit mV. 
SEM (b), standard error of the mean of b. 
df, degrees of freedom and residual degrees of freedom. 
F, F value. 
Sig., p-value, α=0.05. 
R2, coefficient of determination. 
When infant formula was digested with lipase and pepsin, the degree of lipolysis was 
lower relative to digestion with lipase alone. At pH 4.5, there was no significant increase 
with time, and accordingly, we were only able to compare coefficients at pH 3.5 and 5.5 
(Figure 6.5). The slope values at pH 3.5 and 5.5 again showed no significant difference. 
The intercept value of pH 5.5 (a = 67.550±17.764 mV*min) was significantly higher than 
that of pH 3.5 (a = 20.690±12.692 mV*min). This indicated at the first 30 min, the rate 
of lipolysis for the digestate at pH 5.5 was slightly higher than the rate at pH 3.5. However, 






Figure 6.4 Linear regression of FFA increase of infant formula digested with lipase alone in a 




Table 6.2 Pair-wise comparison of the probability of coefficients of the linear regression of FFA 
increase in infant formula digested with lipase alone (α=0.05). 
Intercept 
(a) 
pH 3.5 pH 4.5 pH 5.5 Slope 
(b) 
pH 3.5 pH 4.5 pH 5.5 
pH 3.5 - <0.001 <0.001 pH 3.5 - 0.247 0.309 
pH 4.5 - - <0.001 pH 4.5 - - 0.963 





Furthermore, we were able to compare the intercept and slope values from treatment with 
lipase alone to the values from treatment with lipase and pepsin using the Student t-test 
(Figure 6.6). The slope values of digestion at pH 3.5 with lipase alone (b = -1.679±0.558 
mV) or with lipase and pepsin (b = 0.816±0.235 mV) had no significant difference from 
digestion at pH 5.5 with lipase and pepsin (b = 0.975±0.322 mV), but the slope value of 
digestion at pH 5.5 with lipase (b = 2.607±0.716 mV) was significantly higher than those 
three treatments. The intercept values of digestion at pH 3.5 (with lipase alone) at t = 30 
min had no significant difference from digestion at pH 3.5 or pH 5.5 (with lipase and 
pepsin). However, there a significant difference was observed between the intercept 
values of treatment at pH 5.5 (with lipase alone) and those of both pH 3.5 and pH 5.5 
(with lipase and pepsin). This indicated that there was no significant difference between 
the rate of lipolysis for the first 30 min for digestion at pH 3.5 with lipase alone (a = 
32.287±30.471 mV*min), and digestion at pH 3.5 (a = 20.690±12.692 mV*min) or 5.5 
with lipase and pepsin (a = 67.550±17.764 mV*min). This indicated from 30 min 
onwards, rate of lipolysis for digestion at pH 3.5 (with lipase alone or with lipase and 
pepsin) was the same and was very similar to that of digestion at pH 5.5 with lipase and 
pepsin, whereas the rate for digestion at pH 5.5 with lipase was faster than the previous 
three treatments. 
 
Figure 6.5 Comparison of data of FFA increase of infant formula digested with lipase and 
pepsin in a simulated gastric system. Solid line, regression; dash line, 95% confidence interval 
(regression of pH 4.5 did not show as the regression was not statistically significant). 
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Table 6.3 Pairwise comparison of the probability of coefficients of the linear regression of FFA 
increase in infant formula digested with lipase and pepsin (α=0.05). 
Intercept (a) pH 3.5 pH 5.5 Slope (b) pH 3.5 pH 5.5 
pH 3.5 - 0.038 pH 3.5 - 0.692 
pH 5.5 - - pH 5.5 - - 
 
 
Figure 6.6 Comparison of data of FFA increase of infant formula digested with lipase alone or 
with lipase and pepsin in a simulated gastric system. Solid line, regression; dash line, 95% 
confidence interval. 
Table 6.4 Pairwise comparison of the probability of coefficients of the linear regression of FFA 
increase in infant formula digested with lipase alone or with lipase and pepsin (α=0.05). 
Intercept 
(a) 
3.5L 5.5L 3.5LP 5.5LP Slope 
(b) 
3.5L 5.5L 3.5LP 5.5LP 
3.5L - - - - 3.5L -    
5.5L <0.001 - - - 5.5L 0.309 -   
3.5LP 0.591 <0.001 - - 3.5LP 0.155 0.016 -  
5.5LP 0.406 <0.001 0.038 - 5.5LP 0.275 0.036 0.692 - 
3.5L, pH 3.5 digested with lipase. 
5.5L, pH 5.5 digested with lipase. 
3.5LP, pH 3.5 digested with lipase and pepsin. 




6.3.2 Morphological changes of infant formula during simulated 
gastric digestion using TEM 
The morphological changes of the infant formula emulsion during simulated gastric 
digestion was shown in Figure 6.7 and 6.8. Figure 6.7 showed the changes for lipase only 
and Figure 6.8 for lipase and pepsin. The initial structure (t = 0 min) of the infant formula 
showed an average droplet size of 0.3-0.4 m with flocculated droplets evident at pH 3.5 
or 4.5. At pH 5.5, the oil droplets displayed less propensity towards flocculation. 
When infant formula was digested with lipase alone, the droplet size was observed to 
have reduced in size, and the droplets became amorphous after 120 min at pH 3.5 (Figure 
6.7 A2-A5). The original morphology of the oil droplets disappeared at pH 4.5 after 120 
min of simulated digestion (Figure 6.7 B2-B5). Also, there appeared to be evidence of 
some filamentous structures after 120 min of simulated digestion at this pH level. A pH 
5.5, the droplets showed a propensity towards aggregations, displaying increasing 
anisotropy, but not being significantly reduced in particle size (Figure 6.7 C2-C5). 
When the infant formula was digested with lipase and pepsin, a considerable change in 
structure was observed (Figure 6.8). The assembled structure appeared indicative of 
extensive coalescence of which, surrounded by an interconnected filamentous network, 
which was attributed to the self-association of hydrolysates of proteins and intact proteins 
on the interface of oil droplets as well as in the aqueous phase. These structures were seen 





Figure 6.7 Images of TEM of Infant formula digested with lipase alone in a simulated gastric system. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, pH 




Figure 6.8 Images of TEM of Infant formula digested with lipase and pepsin in a simulated gastric system. A1, pH 3.5 at 0 min; A2-A5, pH 3.5 at 120 min; B1, 




The gastric digestion of formula emulsions was studied under in vitro conditions, with 
the rationale that separate applications of lipase and combined lipase-pepsin would 
provide an indication of their respective roles in the lipolysis of emulsion droplets. 
Digestion behaviours, both in terms of generation of fatty acid and emulsion structure 
were seen to vary according to both pH and enzyme combination. 
6.4.1 Lipolysis from 0 to 30 min – lipase alone 
For emulsion digestion in the absence of pepsin, findings from GC indicated that the rate 
of lipolysis showed significant difference among three different pH conditions for the 
samples containing lipase in the absence of pepsin, as determined by the intercept values 
at t = 30 min (Figure 6.4). Noting that the extent of lipolysis increased as pH was 
increased from 3.5 to 5.5, this would suggest that this effect was primarily governed by 
the relative pH activity of the enzyme. As HGL lipase is an acid-stable lipase and 
possesses an optimal pH of 3.0 to 6.0 (Carriere et al., 1991; Gargouri, Sarda, et al., 1986; 
Roussel et al., 1999; Ville et al., 2002), this allows it to digest triglycerides across a broad 
spectrum of digestive pH, though it does become increasingly less active towards fasting 
pH conditions (Gargouri, Sarda, et al., 1986). In contrast, the fungal gastric lipase used 
in this study has its optimally active at pH 7.0 (pKa of histidine is 6.5 in its Ser-His-Asp 
catalytic triad) (Aloulou & Carrière, 2008; Salah et al., 2006). Thus, it is not necessarily 
surprising that the relative rate of digestion would decline under increasingly acidic 
conditions, as indicated in Figure 6.5. 
The extent of lipolysis observed at pH 5.5 also indicates that the proteinaceous interface 
of the droplets does not appear to be inhibitory to lipase adsorption. Decreasing pH 
towards the isoelectric point might, however, be expected to influence both the interfacial 
structure of the protein and continuous phase structure which could in turn influence the 
lipolysis behaviours observed. Figure 5.6 has shown that, at the commencement of 
digestion, at pH 5.5 the emulsion droplets were stable and non-interacting. In contrast, at 
pH 4.5 and 3.5, flocculation of the emulsion was observed. As pH approaches the 
isoelectric point of the proteins, interactions between the adsorbed protein layer of the 
emulsion droplets and the surrounding serum protein phase could lead to the formation 
of coagulated protein-droplet structures. It can be speculated that the access of the lipase 
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enzyme is optimised when droplets are non-aggregated, and for which the entirety of the 
surface is available for lipase adsorption. In contrast, aggregated structures may reduce 
the availability of binding sites for lipase adsorption. While it is argued that the relative 
pH activity of the enzyme, the predominant effect of extent of lipase during the first 30 
min of digestion, and the variations in emulsion structure, as observed in Figure 6.7, may 
separately impact on the degree of lipolysis during the early stages of digestion. 
6.4.2 Lipolysis from 30 to 120 minutes – lipase alone 
While significant differences in rates of lipolysis were observed over the first 30 min of 
digestion, it is interesting to note that the relative rate of change of lipolysis after 30 min 
through to the end of digestion was shown to be equivalent across all three pH conditions. 
One further curious observation was that no plateau levels of FFA were observed for any 
of the samples regardless of relative pH over 120 min of digestion. Approximately 10-
30% of lipolysis occurs during gastric digestion, with the remainder occurring in the small 
intestine. The lower the levels of lipolysis in the stomach are usually attributed to the 
accumulation of FFA at the interface of fat droplets (Pafumi et al., 2002). In the absence 
of bile salts, which assist in the solubilisation and removal of FFA from the interfacial 
layer, the accumulation of surface fatty acids ultimately becomes inhibitory to the 
adsorption of gastric lipase and limits its access to the triglyceride substrate. That no 
plateau level was observed may be due to fungal, rather than human gastric lipase, being 
used in the study. Additionally, it may be argued that the reaction has not proceeded to 
the point of droplet surface saturation by free fatty acids had occurred. 
While GC data shows that the rate of increase of FFA to be comparable across all pH 
conditions, noticeable structural differences were observed to the emulsion droplets 
during this period. At pH 3.5 and 4.5, after 120 min of digestion, flocculated structures 
could still be observed. As has already been discussed, the formation of coagulated 
protein-fat networks under conditions approached protein pI was observed at 
commencement of digestion. In the absence of pepsin, it seems reasonable that these 
structures would persist for the duration of incubation, and lipolysis appears to have little 
influence on the emulsion structure under these conditions. 
After 120 minutes, droplets at pH 5.5 was also observed to be agglomerated (noting that 
aggregation was not observed at the onset of digestion). Flocculation under theses pH 
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conditions is considered a direct consequence of lipolysis. Based on the observations in 
Figure 6.7, it is suggested that fatty acid displacement of the adsorbed protein layer of 
emulsion droplets during lipolysis reduces both charge stabilisation and droplet repulsion. 
These adsorbed polar lipids can form a variety of crystalline and soft condensed layers at 
the surface of oil droplets depending on fatty acid types (Pafumi et al., 2002). This surface 
crystallisation may be a mechanism for the droplet anisotropy observed in Figure 5.6 and 
is similar to the observations made by Gallier et al. (2013) in their study where a lipid-
structured phase was observed at the interface of milk fat globules when digested milk in 
a gastric digestion study conducted in rats. Moreover, such interfaces can be rendered 
sticky, leading to droplet aggregation as observed by Pafumi et al. and others (Gallier et 
al., 2013; Pafumi et al., 2002). 
6.4.3 Lipolysis from 0 to 120 min – lipase and pepsin 
The inclusion of pepsin to the gastric fluid was seen to alter the digestion behaviours of 
the emulsion depending on pH conditions. As indicated in the findings, the impact on 
lipolysis was most noticeable at pH 5.5, displaying a considerable decrease in rate and 
extent of lipolysis during the first 30 min of digestion when compared to the sample 
digested by lipase alone. At pH 3.5, no significant changes were observed relative to the 
sample with lipase alone, noting that the overall extent of lipolysis was lowest under 
theses pH conditions. At pH 4.5, the raw data suggests that inclusion of pepsin results in 
a reduction in the extent of lipolysis relative to the sample containing lipase alone, 
however, the high degree of variability across samples at this pH makes it difficult to 
verify this finding. 
The observation that the inclusion of pepsin to the simulated gastric fluid appears to 
reduce the rate and extent of lipolysis (at least at pH 5.5) appears contradictory to the 
initial hypothesis of the research that interfacial pepsinolysis would facilitate lipase 
adsorption for protein-stabilised emulsions by rendering the adsorbed layer more 
hydrophobic. There are several possible mechanisms to explain these observed 
behaviours. The first of these relates to the design of the study, and the use of the fungal 
lipase as an alternative to human gastric lipase. From a biological viewpoint, human 
gastric lipase is a highly glycosylated enzyme and is resistant to pepsinolysis, which is 
essential for it to retain activity during digestion. The use of fungal lipase analogue 
presents the possibility (as it may not as glycosylated as human gastric lipase) that the 
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lipase is hydrolysed during digestion by the inclusion of pepsin, leading to a loss of 
activity. While this would certainly account for the generic low extent of lipolysis 
observed under all pH conditions, it would be noted that fungal lipases have been used 
widely in the in vitro studies in combination and speculated to not be compromised in 
terms of activity due to hydrolysis of the enzyme by pepsin. Additionally, while a 
significant reduction in the degree of lipolysis was observed at pH 5.5 when pepsin is 
included, the activity of the pepsin should be relative, low at these pH conditions, at least 
likely to affect the functionality of the lipase. 
Another possible explanation for the differences in measured results is related to sampling 
issues during analysis, which in turn can be related to significant changes to emulsion 
structure during digestion when pepsin was included in the simulated gastric fluid. The 
sampling method of emulsions for GC analysis was made challenging due to increasing 
separation of the emulsion during gastric digestion under conditions where both enzymes 
were present. 
This separation is believed to be primarily a consequence of proteolysis of the interfacial 
layer, which is responsible for the change in structures observed in TEM in Figure 6.8. 
After 120 min digestion completed, absence of the initial spherical droplet distribution 
was observed across all three pH conditions. Instead, a network of aggregated filaments 
was observed surrounding highly anisotropic structures. These filaments were attributed 
as assemblies of protein formed through a combination of pH and protein hydrolysis. The 
darker anisotropic regions within the protein network, most notably at pH 5.5, are 
assumed to be coalescent fat droplets. However, at pH 3.5 and 4.5, the voids within the 
protein network appeared unstained, suggesting an absence of fat. These are interpreted 
as being ghost structures caused by the increasing destabilisation of the emulsion leading 
to extensive coalescence and phase separation of oil from with the structures. The 
observations are supported by previous work using particle size analysis which showed 
increasing particle size of formula milk during digestion with lipase and pepsin 
(Lueamsaisuk et al., 2014). 
Proteolysis of the interfacial layer could cause detachment of polar polypeptides and 
retention of hydrophobic domains at the oil/water interface promoting flocculation of 
droplets, even for pH conditions away from the pI of the proteins. Secondly, loss of 
mechanical stabilisation of the interface arising from proteolysis promotes coalescence 
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of droplets which is exacerbated by increased droplet-droplet contact as a result of 
flocculation. 
As stated earlier, the loss of emulsion structure during digestion was problematic in trying 
to achieve homogeneous sampling throughout incubation. However, it is also worth 
noting that the extensive coalescence observed in the TEM images (Figure 6.8) would 
have the effect of decreasing the relative surface area of the emulsion during digestion, 
thereby reducing the availability of binding sites for lipase adsorption. This would itself 
contributed to a decrease in relative extent of lipolysis, providing a third possible 
explanation as to the apparent reduction in overall lipolysis relative to emulsion digested 
with lipase alone. 
6.5 Conclusions 
In summary, this study provided further insight into the effect of protein interface in the 
process of gastric lipolysis by studying a commercial powder infant formula in a 
simulated gastric system. The results showed that proteins on the interface of the oil 
droplets do not appear to block lipases from accessing their substrate at the oil core. The 
rate of lipolysis was dominated by the ambient pH level when there was only the presence 
of lipase in the simulated digestive system. The higher the pH, the closer it was to the 
optimum activity, and the faster the rate could be achieved. When there were pepsin and 
lipase presented in the digestive system together, pepsin did not act as a facilitator to the 
protein barrier on the oil/water interface. On the contrary, pepsin could inhibit lipase on 
the interface as those fungi originated lipase might not be as highly glycosylated as human 
gastric lipase. Furthermore, proteolysis of the interfacial layer could cause the loss of 
mechanical strength of the protein interface, which leads to destabilisation of the interface 
and coalescence of the droplets. Moreover, the coalesced oil droplets could also reduce 
the active interface for lipases to adsorb and act on their substrates. For our in vitro study, 
since fungal lipase was still used as the analogue of gastric lipase, a replacement of 
mammal lipases was closer to the stereoselectivity, conformation, and optimal pH to 




Chapter 7 Summary and recommendations 
7.1 Summary 
As has been discussed in the literature review, human studies of infant fat digestion have 
observed that maternal milk emulsion is more efficiently digested in comparison with 
infant formulae. There are many potential structural and physiological levers that may 
contribute to this observation, and it would be unrealistic to attempt to address all of these 
in a single study. Instead, this study has focussed on the specific events occurring during 
the gastric stage of digestion. This study aimed to unravel the effect of structural 
dynamics – in particular, how interfacial layer composition impacts on both proteolysis 
(in the case of protein stabilised emulsions) and lipase adsorption. Furthermore, as to 
whether ongoing changes to emulsion structure during digestion arising from either 
proteolysis and/or lipolysis might further influence the kinetics of lipolysis during gastric 
incubation. Following these objectives, this study has shown several relevant findings. 
In this study, in order to investigate how differences in interfacial composition between 
maternal milk and infant formulae could lead to different gastric lipolysis outcomes, three 
different types of interfaces (phospholipid, phospholipid-protein and protein) with same 
fat content (3.6% w/v, different fat compositions) were investigated. The main difference 
of the interface was whether there were dairy proteins being partitioned into the interfaces 
of the oil droplets. As discussed in Chapter 2.5, the initial characteristics of the different 
interfaces (with or without the partitioning of protein) may change under the impacts of 
the neonatal gastric fluids, especially the dynamic gastric pH. For the monolayer 
phospholipid interface, the microscopic results in Chapter 5 showed that pH did not have 
an impact on the size or morphological characteristics of the oil droplets. Similar findings 
were observed in the study of Lueamsaisuk et al. (2015) of maternal milk fat droplets that 
were majorly consisted of phospholipid. This may imply that the acidic environment 
could have little influence on the relative stability of oil droplets from the maternal milk 
at the commencement of gastric digestion. When milk proteins were adsorbed at the 
interface after homogenisation, aggregation of these droplets was induced when the pH 
level approached the pI point of the proteins. Protein coated and phospholipid coated 
simulated milk emulsions already started to show differences at the commencement of 
gastric digestion. Flocculation of protein-stabilised droplets during digestion was further 
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exacerbated to proteolysis of the interfacial layer. The detachment of interfacial polar 
domains would be expected to render the interface both more hydrophobic and 
structurally weaker, leading to greater attraction and increasing incidence of coalescence. 
Arguably the significant differences in structure development between phospholipid and 
proteinaceous emulsions might be expected to manifest itself in changes to the relative 
rate and extent of lipolysis, which was the additional focus of this study. 
The study attempted to correlate the kinetics of lipolysis during in vitro gastric digestion 
to structural dynamics. However, confirming this hypothesis was difficult due to 
challenges in getting statistically significant lipolysis data. While some samples showed 
good reproducibility (i.e. for fatty acid generation over the incubation period) within 
sample sets, other compositions showed significant variation within a given sample set. 
Visual observations showed this to be mainly the case of emulsions that underwent 
significant destabilisation and phase separation during the digestive process, which made, 
homogeneous sampling very difficult. However, given that all samples displayed 
evidence of lipolysis (regardless of the extent of variation within a sample set), it could 
be argued that the protein coating, either for lactoferrin-coated Intralipid droplets or 
combined whey/casein in the case of the infant formulae, was not ultimately inhibitory to 
the adsorption of lipase (even in the absence of pepsin). This is somewhat counter to the 
original hypothesis of the research, which postulated that the lipolysis of protein-
stabilised emulsions may be less effective under conditions for which pepsin is less able 
to hydrolyse the interfacial layer (such as those in early infancy, and where a combination 
of lower pepsin activity and higher gastric pH conditions may render gastric proteolysis 
less effective). Curiously enough, the inclusion of pepsin as part of the simulated gastric 
fluid appeared to induce far greater structural changes (particularly flocculation and 
coalescence) to the emulsion systems compared to samples where it was excluded. 
Unfortunately, the large variation in GC data made it difficult to determine the impact of 
these structural changes on the digestibility of the emulsions. 
A final interesting observation of the GC analysis showed that lipolysis did not reach 
equilibrium during the incubation period. This may be due to insufficient reaction time to 
saturate the interface with fatty acids that would consequently inhibit further lipase 
adsorption and lipid hydrolysis as suggested from the study by Pafumi et al. (2002). 
In conclusion, the research findings presented in this thesis has built the bridge of 
understanding the relations between the structural dynamics and gastric lipolysis for 
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infant milk with different types of interfaces in a simulated neonatal gastric system. 
Especially using low shear rate in this study could allow the shear rate in the model more 
closely simulating the physiological low shear environment in the digestion of human 
gastric phase compare to high shear rate that were commonly used in other in vitro models.  
The findings also gave new insights into the separate and combined action of digestive 
enzymes that are crucial for infant fat digestion in the gastric phase. However, several 
limitations presented in this thesis such as the use of fungal lipase, static pH over time in 
the model and show that future work is necessary to unveil the influences of interfaces 
and fat composition of infant milk droplets to the digestibility of fat in the infant gastric 
phase, the impacts on the lipid digestion in the small intestine and mechanisms in human 
physiology. 
7.2 Recommendations for future work 
• Sampling for GC measurement was an ongoing issue across the studies in this thesis. 
The phase separation due to enzymatic reactions has caused difficulties in sampling 
and reduced the accuracy of lipolysis data. The large variation in the data points has 
made the statistical analysis very challenging. Though the sampling issue has not 
been reported in the previous in vitro studies (possibly due to less extreme structural 
transformations), it is still a key point to resolve in experimental designs, either in 
terms of the sampling model for GC or in the context of any other analysis that might 
be useful for determining fatty acid composition. 
• Further optimisation of the in vitro model may be useful. For example, our simulated 
gastric digestion has used a very low stirring rate (10 rpm) instead of the commonly-
used high stirring rate (100 rpm) in many in vitro studies. This low shear rate was 
much closer to the physiological circumstance in the infant's stomach, which created 
a much lower shearing force compared to those studies. The concern of the high 
stirring rate (high shearing forces) is that it could lead to more collisions for the 
droplets and thin the protein interface (Miller & Möbius, 1998) which may increase 
the probability for the occurrence of droplet instability. A faster encounter of 
digestive enzymes to the oil/water interface may also lead to an elevated reaction rate. 
These two factors may together mislead the interpretation of the results. Ensuring 
that the mechanical action of samples during simulated digestion is close to 
physiological equivalents is key to obtain relevant data. 
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• The use of three types of interfaces in this thesis in order to mimic the difference 
between infant formulae and maternal milk has provided clues for their impacts on 
infant gastric fat digestion. However, since the triple-layered structure of human milk 
fat globule is much more complicated than the artificial-built interfaces for the oil 
droplets in model emulsions and infant formulae. Studies that involve fresh human 
breast milk would be still demanding to verify the findings in this thesis. 
• Fungal lipase was used as an analogue of human gastric lipase in this thesis due to 
the difficulty and expenses of sourcing commercial suppliers for recombinant human 
gastric lipase. However, as discussed in Chapter 2.4, it was not a fully equivalent 
alternative for human gastric lipase. Examples for better alternatives are lipases from 
mammal origins such as dog and rabbit gastric lipase, which have been already 
included in many in vitro digestive system designs (Brodkorb et al., 2019; Sams, 
Paume, Giallo, & Carriere, 2016). The future in vitro study designs for gastric lipid 
digestion should preferably use these lipases instead of lipases from fungal origins. 
• Human trials and in vivo studies, including direct incubation and collection of gastric 
content would be needed to support the evidence presented in this thesis. The 
complications of physiological circumstances in the gastric phase of infants would 
change the scenario compared to studies conducted in vitro. 
• Measurement for lipolytic products such as FFA, MG, DG and TG for improved 
accuracy would be needed in future studies. The GC and 1H NMR methods presented 
in this thesis have provided possibilities of investigating novel and accurate 
methodology for the measurement of these compounds. The development of the 
methodology for monitoring human gastric lipolysis in real-time (including pH and 
lipolytic products) could provide valuable new insights for the impacts of the 
dynamic environment in the gastric phase on fat digestion. Additional challenges in 
this context will be ensuring baseline levels of free fatty acids are calculated before 
digestion and ensuring effective data collection starts with the addition of digestive 
enzymes (i.e. at t = 0 min), as well as being able to entirely inactive digestive 
enzymes on the completion of the incubation period. 
• The surface mechanisms and surface structural changes during gastric lipolysis are 
also promising and exciting new areas to be explored in the future. Some studies have 
shown that gastric lipase exhibited different adsorption behaviours to the interface of 
milk emulsions (Bourlieu-Lacanal et al., 2015; Bourlieu et al., 2020). Advanced 
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microscopic methodology such as atomic force microscopy (AFM) could be further 
developed to investigate the interfacial structure and mechanical properties of lipid 





A1 Parameters of the linear regression of the normalised FFA increase for the first 30 min for Intralipid and lactoferrin 
coated Intralipid digestion 
























a -1.124 -1.070 -0.962 -1.151 -1.046 -1.118 - - -1.094 -1.137 -0.783 -1.177 
SEM (a) 0.102 0.126 0.117 0.060 0.064 0.011 - - 0.056 0.220 0.194 0.031 
b 0.043 0.019 0.016 0.026 0.031 0.029 - - 0.016 0.047 0.046 0.027 
SEM (b) 0.005 0.007 0.007 0.003 0.004 0.001 - - 0.003 0.011 0.012 0.002 
df 1;7 1;9 1;10 1;10 1;10 1;9 1;6 1;9 1;10 1;7 1;8 1;9 
F 65.932 6.666 5.546 54.831 67.165 1481.960 0.187 0.173 23.809 17.335 14.075 246.035 
Sig. <0.001 0.030 0.040 <0.001 <0.001 <0.001 0.681 0.688 0.001 0.004 0.006 <0.001 
R2 0.904 0.425 0.357 0.846 0.870 0.994 0.030 0.019 0.704 0.712 0.638 0.965 
CL, Intralipid digested with lipase alone. 
CLP, Intralipid digested with lipase and pepsin. 
LfL, lactoferrin coated Intralipid digested with lipase alone. 
LfLP, lactoferrin coated Intralipid digested with lipase and pepsin. 
a, intercept value. 
SEM (a), standard error of the mean of a. 
b, slope value. 
SEM (b), standard error of the mean of b. 
df, degrees of freedom and residual degrees of freedom. 
F, F value. 
Sig., p-value, α=0.05. 
R2, coefficient of determination
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A2 Pair-wise comparison of the probability of coefficients of the linear regression of FFA increase in Intralipid and 


























pH 3.5 CL - 0.707 0.673 0.732 0.823 0.740 - - 0.588 0.957 0.969 0.730 
pH 4.5 CL - - 0.963 0.897 0.834 0.841 - - 0.956 0.712 0.726 0.879 
pH 5.5 CL - - - 0.854 0.793 0.797 - - 1.000 0.679 0.692 0.836 
pH 3.5 CLP - - - - 0.916 0.932 - - 0.812 0.739 0.760 0.980 
pH 4.5 CLP - - - - - 0.962 - - 0.742 0.809 0.826 0.926 
pH 5.5 CLP - - - - - - - - 0.714 0.759 0.785 0.948 
pH 3.5 LfL - - - - - - - - - - - - 
pH 4.5 LfL - - - - - - - - - - - - 
pH 5.5 LfL - - - - - - - - - 0.624 0.648 0.779 
pH 3.5 LfLP - - - - - - - - - - 0.991 0.746 
pH 4.5 LfLP - - - - - - - - - - - 0.770 
pH 5.5 LfLP - - - - - - - - - - - - 
 
CL, Intralipid digested with lipase alone. 
CLP, Intralipid digested with lipase and pepsin. 
LfL, lactoferrin coated Intralipid digested with lipase alone. 
LfLP, lactoferrin coated Intralipid digested with lipase and pepsin.
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A3  Changes in the triglycerides for digestion of a protein emulsion 
using a simulated neonatal gastric system 
 
A, Intralipid digested with lipase alone (L); B, Intralipid digested with lipase and pepsin (L+P); C, 
lactoferrin coated Intralipid digested with lipase alone (Lf-L); D, lactoferrin coated Intralipid digested 




A4 Ingredient information for S-26® Gold Newborn infant formula 
 
Average as per 100 mL prepared (12.7 g powder + 90 mL water) 
Energy 281 kJ 
Protein 













Milk solids, vegetable oils (including soybean), emulsifier (soy lecithin), taurine, nucleotides 
(cytidine-5′-monophosphate, disodium uridine-5′-monophosphate, adenosine-5′-
monophosphate, disodium inosine-5′-monophosphate, disodium guanosine-5′-
monophosphate), L-carnitine. 
 






A5 Fatty acid profile of the oil blend of S-26® Gold Newborn infant 
formula 
According to the oil blend on the ingredient label of S-26® Gold Newborn Infant 
formula, the oil blend was consist of coconut oil, palm oil, soybean oil, sunflower and 
safflower oil. There was no indication of the percentage of each oil in the oil blend. The 
figure below showed the fatty acid profile of each oil in the oil blend of this infant 





A6 Fatty acid profile of S-26® Gold Newborn infant formula 
The figure below shows the fatty acid profile of S-26® Gold Newborn infant formula 











A8 GC chromatogram examples of triglycerides  in the digestion of a 
powder infant formula using a simulated neonatal gastric system 
Overlapped chromatograms of infant formula digested with lipase alone at pH 4.5 (blue 
and black lines showed the beginning and the end of simulated digestion). 
 
Overlapped chromatograms of infant formula digested with lipase alone at pH 4.5 (blue 
and black lines showed the beginning and the end of digestion, other colours showed 
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